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ABSTRACT 
The Impact of Psychosocial Variables on 
Immune System Functioning in a 
Sample of HIV-Positive Males 
by 
Gary K. Richey, Doctor of Philosophy 
Utah State University, 1992 
Major Professors: Ors. Elwin C. Nielsen and William R. Dobson 
Department: Psychology 
Vi i i 
This study addressed the issue of the relationship between 
psychological well-being and immune function in a sample of HIV 
seropositive homosexual and bisexual males. A control group of HIV 
seronegative gay males was included. The study assessed the 
relationship between various psychological independent variables and 
immune system functioning over a 24-month time period for the 
seropositive subjects. Data on depression, coping style, psychosocial 
stress, and psychosomatic symptoms were collected at baseline, as well 
as data on depression at 12 months and CD4 counts at 6-month intervals 
over a 2-year period. Preliminary analyses comparing HIV seropositive 
to HIV seronegative subjects showed differences on four of eight coping 
style scales, as well as on all of the psychogenic attitudes scales 
reflecting stress levels. 
There were no effects of eight coping styles on immune system 
functioning for the seropositives. However, there were significant 
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relationships among four of six psychogenic attitudes scales (chronic 
tension, premorbid pessimism, future despair, and somatic anxiety) and 
immune system functioning for the seropositives. There were also 
significant effects of three scales measuring psychosomatic symptoms 
(Allergic Inclination, Gastrointestinal Susceptibility, and 
Cardiovascular Tendency) for the seropositives. However, there was no 
effect of level of depression on immune system functioning. 
The final chapter discusses the findings given the existing body 
of research. The emphasis is on the need to develop interventions 
targeting stress levels among persons with AIDS, as well as on 
conducting further research utilizing carefully constructed 
longitudinal research designs. 
(140 pages) 
CHAPTER I 
INTRODUCTION 
Background to the Problem 
Acquired Immunodeficiency Syndrome (AIDS) is a disease which 
attacks the body's immune system and renders its victims vulnerable to 
opportunistic illnesses which would otherwise be nonthreatening. AIDS, 
initially identified in 1981 (Centers for Disease Control, 1981), has 
subsequently been traced back to 1979 (Curran, 1983). As of September, 
1992, there were 242,146 reported AIDS cases, with 160,372 having 
resulted in death (CDC National AIDS Hotline, personal communication, 
October 26, 1992). Current projections are that there will be between 
390,000 to 480,000 AIDS cases by 1993. It is also estimated that 1 to 
2 million Americans have been infected with the human immunodeficiency 
virus (HIV) but have no symptoms of the illness. The number of 
affected individuals is constantly increasing, particularly in high-
risk populations (as defined by past or present unprotected sexual 
activity or intravenous drug use). It appears that the absolute number 
of cases is more than doubling every 12 months, although many experts 
believe that the actual occurrence far exceeds reported incidence 
(Quadland & Shattis, 1987). 
-Although approximately three-quarters of all AIDS cases in the 
United States involve homosexual or bisexual men (Harowski, 1987; 
Quadland & Shattis, 1987), AIDS is definitely not restricted to this 
population. It is becoming clear that individuals who engage in 
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certain high-risk behaviors are at risk for AIDS, regardless of 
nembership in any particular group. 
When AIDS was first identified in 1981, it was poorly defined and 
Lnderstood only as "a cluster of rare diseases that had suddenly become 
, larmingly common in homosexual men" (Redfield & Burke, 1988, p. 90). 
Ey 1984, researchers at the Centers for Disease Control and at Walter 
Feed Army Medical Center had developed a more precise definition of the 
cisease. AIDS was redefined as representing the culmination of a 
nulti-stage process through which certain types of white blood cells 
,re depleted. These cells are crucially important in the body's immune 
'.ystem, and are also involved in the process of T-cell activation. 
~ore specifically, they activate B-lymphocytes, which normally multiply 
end produce antibodies that can bind and inactivate infected cells. 
Consequently, the body's resistance to a variety of infections is 
reduced; in particular, the ability of the body to ward off attack by 
,iruses, fungi, parasites, and bacteria is impaired (Redfield & Burke, 
]988). 
In order to develop an understanding of the li nkage between 
1sychosocial variables and immune system functioning, it is useful to 
Explore the way in which the human immune system works. Generally 
~peaking, the immune system's primary function is to identify and 
Eliminate foreign agents that attempt to enter the body (e.g., 
lacteria, viruses, parasites, and fungi). The immune system itself is 
nade up of highly specialized cells that originate in the body's bone 
narrow; after such cells become active, they are concentrated in 
certain organs such as the thymus, the peripheral lymphoid organs, and 
the lymph nodes. The immune cells are then released from these organs 
into the blood stream, where they attempt to ward off the foreign 
antigens. 
The most prominent and functionally important cells in the body's 
immune system are known as leukocytes (white blood cells). These 
leukocytes may be classified as (a) granulocytic cells, (b) monocytes/ 
macrophages, or (c) lymphocytes. The lymphocytes, which make up about 
20% of the leukocytes in the blood, may be either 8-cells or T-cells. 
The T-cells (which derive their name from the fact that they mature in 
the thymus) are the cells that make direct contact with the invading 
agent, and are essentially the primary defense of the immune system. 
Our understanding of the physiological and biochemical effects of 
the HIV virus has increased tremendously over the last few years. 
However, the exact manner in which psychosocial variables affect the 
process of HIV infection is as yet poorly understood. 
Although still in its infancy, there is an important and growing 
body of research attempting to empirically assess the relationship 
between psychosocial factors and immunologically mediated illnesses. 
There are several potential pathways through which the effect of 
psychological variables on the immune system may be expressed, 
including reactivation of latent viruses, reduced functioning of 
peripheral lymphocytes as a result of altered neuroendocrine processes, 
and a greater vulnerability to initial infection (Solomon & Temoshok, 
1990). 
Much of this recent research has focused on the relationship 
between psychological stress and psychological well-being on the one 
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hand and immune system functioning on the other (Jemmott, 1985). The 
current study builds on this literature by focusing on the effects of 
coping styles, stress, and depression on immune system functioning. 
Statement of the Problem 
Persons with AIDS (PWAs) are faced with tremendous challenges in 
all areas of their lives, and it is not surprising that many PWAs fall 
victim to a variety of psychological and neuropsychological 
difficulties, ranging from the expected anxiety to clinical depression 
and dementia. While many of these disorders, particularly in the 
terminal stages, fall into the category of physiologically determined 
neuropsychological disorders, many other disorders are primarily 
psychological in nature. This raises the issue of the relationship of 
psychological well-being to immune function. To the degree that there 
is such a relationship, the prevention and/or mediation of psychiatric 
disorders may be important in limiting the degree of immune system 
breakdown. 
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The current study addressed the issue of the relationship between 
psychological well-being and immune function in a sample of 
seropositive homosexual and bisexual males drawn from the patient 
population at the Veteran's Affairs ~iedical Center in West Los Angeles. 
Research Questions 
This study addressed the following research questions. 
1. What is the relationship between specific styles of coping and 
immune system functioning? Are there certain coping styles that are 
positively related to the body's ability to maintain its immune 
response, despite the HIV infection? 
2. What is the relationship between specific areas of stress and 
immune system functioning? Are some types of stress more closely 
associated with impaired immune system functioning than others? 
3. What is the relationship between psychosomatic symptoms in 
specific areas of the body and immune system functioning? 
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4. What is the relationship between depression and immune system 
functioning? 
The remainder of this chapter will discuss the importance of the 
research problem, present a conceptual framework for the study, and 
define terms as used in the study . 
Importance of the Problem 
As Van Gorp, Satz, Hinkin, Evans, and Miller (1989) pointed out, 
it is somewhat difficult to compare the results of various studies of 
psychological functioning, neurological impairment, and immune system 
functioning in this population due to a lack of definitional clarity. 
While there has been some recent research addressing the relationship 
between psychological functioning and immune system function, many 
existing studies suffer from methodological limitations. There are 
inherent difficulties involved in obtaining reliable responses from 
HIV-infected subjects, particularly in terms of neuropsychological 
instruments. Many studies have not clearly differentiated between 
symptomatic and asymptomatic patients, thus making it more difficult to 
distinguish the dynamics in an HIV-infected population. Other 
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weaknesses have included poorly selected control groups and failure to 
control for possible confounding variables such as anxiety, depression, 
and neurological disorders. 
Nevertheless, there is an emerging body of literature suggesting 
that psychosocial variables play an important role in influencing 
immune system functioning in HIV-spectrum illness (Temoshok, 1988). 
The exact nature of this relationship is unclear, however, and may vary 
considerably depending on the stage of the illness. 
The current study represents an improvement in research 
methodology compared to much previous research. The study tapped into 
an existing pool of HIV seropositive subjects already participating in 
research at the West Los Angeles Veterans Affairs Medical Center, and 
utilized a control group of seronegative gay male subjects. The sample 
of HIV seropositive subjects also included individuals at various 
stages of the illness, allowing systematic comparisons to be done. 
The study also had the advantage that CD4 data were collected at 
6-month intervals for a 2-year period, allowing the relationship of 
baseline measures of psychological functioning to be correlated and 
compared to outcomes over a period of time. The longitudinal component 
of the study should strengthen the validity of study findings and allow 
a more objective assessment of the effects of psychological 
characteristics (e.g., coping style, depression) on immune system 
functioning over a period of time. In addition, a variety of 
methodological tools were used to assess the research questions. Each 
of the instruments utilized has been shown to be reliable and valid in 
previous research, with the concepts being measured quite clearly 
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defined. This should contribute to the definitional clarity of the 
proposed study. 
The importance of the current study is also reflected in the 
growing interest among AIDS researchers regarding the specific 
psychological effects of AIDS on PWAs. This interest is illustrated by 
research presented at the recent Eighth International AIDS Conference 
in Amsterdam (Burack, Stall, Barrett, & Coates, 1992). Burack et al., 
in a study conducted at the University of California, San Francisco, 
studied 330 gay and bisexual men who were part of the San Francisco 
Men's Health Study (J. Burack, personal communication, August 19, 
1992). Researchers found that HIV-infected men who were depressed 
exhibited a much more rapid decline and death. They found that CD4 
counts dropped 38% faster among depressed subjects than in non-
depressed subjects. More specifically, the average rate of CD4 cell 
decrease was 81 cells per microliter among depressed subjects as 
compared to 59 cells per microliter among nondepressed subjects. The 
current study will elaborate this line of research. 
More generally, the findings of the current study on the 
relationship between specific coping styles and immune system 
functioning should be valuable in helping therapists design 
interventions for PWAs. Coping strategies shown to be correlated with 
impaired immune system functioning are explored, as is the relationship 
between various types of stress and immune system functioning. The 
results provide some guidance for interventions designed to teach 
individuals to switch to more productive coping styles. By enlarging 
our knowledge of coping styles among AIDS patients, it should be 
possible to develop appropriate interventions to be put into effect 
prior to the patient's becoming symptomatic. Ultimately, such 
interventions could be valuable in enhancing the quality of life for 
persons living with AIDS. 
Theoretical Framework 
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The traditional biomedical model focuses on the identification and 
treatment of disease. The basic assumption of this approach is that 
any disease is a pathological process which can be observed, and for 
which the cause can be empirically identified (Shaver, 1985). Engel 
(1977) pointed out that the underlying philosophical approach of the 
biomedical model is one of reductionism; it is assumed that complex 
phenomena can be broken down into their component parts. 
Originally developed by Descartes, this principle lies at the core 
of most modern medicine. Although there were some nineteenth century 
physicians and researchers who were aware that disease should be seen 
as involving psychological as well as physiological variables, they 
were the exception rather than the rule. 
In contrast to this approach, the current research assumes that it 
is necessary to distinguish between disease and illness (Pfifferling, 
1983). "Disease" refers to the specific medical diagnosis, and is 
consistent with the way most physicians trained in the biomedical model 
vievv t heir patients. "Illness," in contrast, refers to the overall 
condition of the individual, encompassing social and psychological 
variables as well as physical. The key point is that it is essential 
to distinguish the various components of illness, and to 
reconceptualize health care in terms of a health-i l lness continuum. 
The Emerging Field of Psychoneuroimmunology 
9 
Some of the most interesting research is being done in t he area of 
psychoneuroimmunology (PNI), an evolving, multidisciplinary field 
dealing with the interactions of psychological factors such as emotions 
and behavior, the central nervous system, and the immune system. The 
origins of the field can be traced to the work of Solomon and Moos 
(1964), who coined the term "psycho immunology" to refer to the effects 
of psychological and psychosocial variables (such as stress, affects, 
traits, and coping styles) on the onset and course of immunologically 
related diseases. At that time, Solomon and Moos proposed the single 
speculative hypothesis that "stress can be immunosuppressive." 
Early psychoimmunology research focused on the effects of acute, 
short-term stressors on immune system functioning. Research by Solomon 
(1969) demonstrated the stress-induced suppression of the immune system 
in rats. The somewhat broader term psychoneuroimmunology (PNI) refers 
to the general realm of the complex interactions between the central 
nervous system and the immune system (Ader, Felton, & Cohen, 1991). 
PNI has been defined as a: 
... multidisciplinary field dealing with the complex 
bidirectional interactions of psychological factors, such as 
emotions and behavior, the central nervous system, and the 
immune system. (Solomon & Temoshok, 1990, p. 240) 
One of the early studies that inspired further research was 
carried out by Locke (1982), who found that the blood samples of Apollo 
III astronauts taken during the recovery phase of a space mission had 
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elevated white blood cell counts. He hypothesized that the stress 
involved in space flight leads to an increased invasion of antigens, 
which explained the elevations in white blood cell counts. 
The specific nature of stress and its controllability are critical 
issues in psychoneuroimmunology research. Given the inherent 
variability of stressful stimuli and the fact that individuals 
continually learn new coping strategies, physiological and biological 
responses are not stereotyped. Borysenko (1984), for example, surveyed 
the various mechanisms involved in immune system response, and cited 
various research findings supporting the mind1 s role in enhancing that 
response. She developed a model of immune system responses integrating 
hereditary, environmental, and behavioral variables as predictors of 
disease susceptibility. Her model is based on the premise that disease 
can be caused by any of these three variables acting in isolation, or 
that it may be caused by two or more of the variables acting 
simultaneously. For example, certain diseases involve genetic factors 
and are associated with particular histocompatibility types; at the 
same time, the disease may have been exacerbated by exposure to an 
environmental agent (e.g., a pathogen). Similarly, behavioral 
variables may interact by compromising the body1 s immune function, 
creating a predisposition to infection by a disease-specific pathogen. 
However, the disease might have occurred as a result of the original 
genetic factor acting alone. 
Gorman and Kertzner (1990) explored the nature of the relationship 
between cognitive functioning and immune system functioning, with 
particular reference to human immunodeficiency virus immunopathology. 
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They pointed out that there is an emerging body of research using both 
animals and human subjects supporting the argument that there is an 
ongoing reciprocal relationship between the central nervous system 
(CNS) and the immune system. Among the variables identified as most 
important is the reduction in sympathetic tone and noradrenergic 
turnover in the hypothalamus and the peripheral lymphoid organs that 
occurs during an acute immune response. These reductions suggest that 
psychological states, and particularly depression, may have an 
immunosuppressive component. 
In summary, the psychoneuroimmunological perspective provides the 
basis for developing testable hypotheses with regard to human 
T-lymphotropic virus Type III (HTLV-III) diseases. Solomon and 
Temoshok (1987) derived nine such hypotheses, dealing with the effects 
of stress on HTLV-III, correlations between psychological variables and 
alterations in immune function, the effects of the prenatal endocrine 
environment on sexual orientation and immune competence, and the 
influence of psychological interventions on psychic distress associated 
with AIDS. 
The implication of adopting such an approach is that the research 
study must attempt to assess the effects on the immune system of 
stress, emotions, personality, cognition, and other psychological 
variables (Jemmott, 1985). PNI represents a major departure from 
previous approaches to the study of immunologic processes in that the 
immune system has traditionally been conceptualized as being autonomous 
from and unaffected by psychological variables. However, a 
considerable body of research now suggests that psychological variables 
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have a significant influence on che body's susceptibility to conditions 
that are associated with impaired immunologic functioning. This impact 
of psychological variables may be particularly salient in the case of 
Persons with AIDS. 
The PNI framework implies that it is insufficient to focus on 
immunologic factors alone; instead, it is essential to incorporate a 
variety of other potential independent variables into the research 
design (Ratliff, Temoshok, Kiecolt-Glaser, & Tamrakin, 1990). Other 
important blocks of variables to be considered include: 
1. Antecedent variables such as age, sex, and sociodemographic 
background; 
2. Use of common medications such as beta-blockers for 
hypertension; and 
3. Psychological distress, including especially levels of anxiety 
and depression. 
Theories of Personality and Implications 
for Measurement 
Researchers exploring the relationship between personality 
characteristics and disease have generally focused on one of several 
alternative dimensions (Millon, Green, & Meagher, 1979). Some 
researchers have focused their attention on personality style, which 
can be defined as a set of enduring personality traits which shape the 
individual's susceptibility to a disease, as well as how one copes with 
the disease after its onset (Kahana, 1972; Lipowski, 1977). The 
underlying assumption of this approach is that the individual's 
personality characteristics form a consistent matrix that strongly 
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influences the way the individual reacts to the stimuli presented by 
the disease. These reactions encompass the dimensions of emotions, 
cognition, behavior, and the body's physiolo gical responses. 
Other researchers have concentrated on specific psychological 
traits rather than an overall personality pattern. Examples of this 
approach include studies on the impact of chronic stress on onset and 
progress of disease (Holmes & Masuda, 1974; Rahe, 1977); the effects of 
the learned helplessness syndrome (Boyd, Yeager, & McMillan, 1973); and 
the effects of social isolation (Cobb, 1976). 
Another, and ultimately more productive approach, has emphasized 
the overall coping ability of the individual faced with the disease 
diagnosis. Various researchers have stressed that understanding the 
nature of these per sonality traits and their impact on the coping 
process is cent r ally important (Kahana, 1972; Millon, Green, & Meagher, 
1981). This approach assumes that there are certain enduring 
personality traits that either contribute to or detract from effective 
coping . More specifically, the effects of the personality traits take 
the form of prediposed tendencies to react to stressors with relatively 
predictable patterns of emotional, cognitive, behavioral, and 
physiological responses. 
The current study relies heavily on Millon's (1969) theory of 
personality pathology. Millon noted that most existing 
psychodiagnostic tools are not readily applicable in terms of focus or 
content for the accurate diagnosis of medical patients seen in 
inpatient settings (Millon, Green, & Meagher, 1982). Millon et al. 
(1982) argued that using instruments with psychiatrically oriented 
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norms to assess a medically ill or rehabilitative population is likely 
to yield misleading results. Among the problems noted were 
inappropriate norms and the possibil i t y that inappropriate clinical 
symptoms would be identified. 
In contrast to the traditional view of psychopathology as an 
abnormal phenomenon, Millon argued that: 
Etiology in psychopathology may be viewed as a developmental 
process in which intraorganismic and environmental forces 
display not only a reciprocit y and circularity of influence 
but an orderly and sequential continuity throughout the life 
of the individual. (Millon, 1969, p. 492) 
That is, normality and pathology are seen as endpoints on a continuum, 
with no clear division between the t wo. Millon developed the concept 
of the "personality pattern " to describe the developmental nature of 
intrapsychic processes . He argued th at each individual has certain 
"intrinsic and pervasive modes of functionin g," and that these emerge 
out of a complex developmental histor y. 
Millon argues that personality patt erns should be evaluated 
primarily in terms of coping abilities or styles. A healthy 
personality pattern is characterized by a fle xible and adaptive manner, 
while a pathological personality patt ern is characterized by inflexible 
or defective responses. More specific a lly, Millon defines three 
criteria for evaluating the normal-pathological continuum: adaptive 
inflexibility (rigid use of limited coping strategies); vicious circles 
(attitudes and behaviors that intensify old difficulties and create 
self-defeating consequences); and tenuous stability (lack of resilience 
to conditions of stress). 
15 
The Millon Behavioral Health Inventory (MBHI) is based explicitly 
on Millon's theory of personality. The focus of the instrument is on 
interpersonal behaviors; specifically, the instrument taps information 
regarding the kind of reinforcements sought (positive or negative), 
where the individual looks for help (self or others), and the types of 
behaviors engaged in to acquire reinforcements (active or passive). 
The MBHI has eight primary subscales measuring Coping Strategies, and 
these are directly linked to Millon's theory of personality. 
The key elements of Millon's (1969) theory are defined in terms of 
the interaction of (a) interpersonal style, and (b) nature and source 
of reinforcements. In other words, the two cross-cutting dimensions 
form a matrix with the nature and source of reinforcements defining the 
rows and the passive-active dimension of interpersonal style defining 
the columns. This matri x is shown graphically in Table 1. 
Table 1 
Millon's Personality Matri x 
Detached 
Nature and Source Dependent 
of Reinforcements 
Interpersonal Style 
Passive 
Passive-Detached 
Passive-Dependent 
Active 
Active-Detached 
Active-Dependent 
Independent Passive Independent Active-Independent 
Ambivalent Passive-Independent Active-Independent 
This model was later applied to the development of the MBHI instrument 
(see more detailed discussion in Chapter III). 
Millon 1 s model encompasses eight distinct "normal" variants of 
personality. These are as follows: 
Introversive Style: Keeps to self, unemotional, not easily 
excited, rarely gets socially involved, lacks energy, vague about 
symptoms, passive about self-care. 
Inhibited Style: Shy, socially ill at ease, avoids close 
relationships, fears rejection, feels lonely, distrustful, is easily 
hurt, requires sympathetic support. 
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Cooperative Style: Soft-hearted, sentimental, reluctant to assert 
self, submissive, lacks initiative, eager to take advice, compliant, 
dependent, devalues self-competence. 
Sociable Style: Charming, emotionally expressive, histrionic, 
talkative, stimulus seeking, attention seeking, unreliable, capricious 
in affect, easily bored with routine. 
Confident Style: Self-centered, egocenteric, self-assured, 
exploitive, takes others for granted, expects special treatment, 
benignly arrogant. 
Forceful Style: Domineering, abrasive, intimidates others, blunt, 
agressive, strong-willed, assumes leadership role, impatient, easily 
angered. 
Respectful Style: Serious-minded, efficient, rule conscious, 
proper, correct in behavior, emotions constrained, self-disciplined, 
avoids unpredictable, orderly, socially conforming. 
Sensitive Style: Unpredictable, moody, passively aggressive, 
negativistic, complainer, guilt ridden, anticipates disappointments, 
displeased with self and others. 
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One of the implications of Millon's theory is that psychopathology 
is not the result of outside factors, but rather emerges from the 
individual's existing personality patterns. In a sense, then, 
"normality and pathology " are relative concepts, with no clear dividing 
line between them. Psychopathology occurs as part of an ongoing 
developmental process; more specifically , psychopathology should be 
seen as occurring when an individual adopts certain maladaptive coping 
mechanisms that lead to undesirable outcomes. 
Coping with AIDS 
Coping can be conceptualized as effort s to manage environmental 
stresses and/or to regulate the emotions aroused by the stress 
(Lazarus, 1982). Positive coping strategies such as information 
seeking appear to have a positive influence on adjustment. Information 
seeking may be seen as representing an active, presumably instrumental, 
confrontative approach to illne ss, and thus linked to decreased 
negative affect (Felton & Revenson, 1984). In contrast, wish-
fulfilling fantasy represents an avoidant strategy of diverting 
attention from the reality at hand; thus, it is an indicator of poor 
adjustment. 
Felton and Revenson (1984) conducted a longitudinal study 
exploring the coping strategies employed by middle-aged and older 
adults faced with one of four different chronic illnesses. The study 
design differentiated illnesses offering few opportunities for control 
(rheumatoid arthritis and cancer) from illnesses more responsive to 
individual and medical interventions (hypertension and diabetes). 
Results showed that patients who sought out information (as a primary 
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coping strategy) had better psychological adjustment than patients who 
coped using wish-fulfilling fantasies. 
The clinical implication is that efforts to prevent mental health 
problems among normal adults faced with serious illness (such as AIDS) 
might fruitfully be directed at boosting the use of information seeking 
and at breaking the destructive cycle in which poor adjustment and 
wish-fulfilling fantasy reinforce each other's ill effects. 
Definition of Terms 
AIDS (group IVC) (Centers for Disease Control, 1986). A diagnosis 
of AIDS is warranted when any of several conditions exist in an HIV 
positive individual. These conditions include Pneumocystis carinii 
pneumonia, an opportunistic neoplasm (e.g., Kaposi's sarcoma), and 
dementia. 
HIV-related encephalopathy. This may be defined as: 
... Clinical findings of disabling cognitive and/or motor 
dysfunction interfering with occupation or activities of 
daily living, or loss of behavioral developmental 
milestones ... progressing over weeks or months, in the absence 
of a concurrent illness or other condition than HIV infection 
that could explain the findings. Methods to rule out such 
concurrent illness and conditions must include cerebrospinal 
fluid examination and either brain imaging or autopsy. 
(Centers for Disease Control, 1986) 
The American Academy of Neurology AIDS Task Force, working 
collaboratively with the researchers developing upcoming versions of 
the International Classification of Diseases (ICD-10) and the 
Diagnostic and Statistical Manual of the American Psychiatric 
Association (DSM-IV), has recently developed a revised, clinically 
sensitive set of diagnostic criteria for AIDS (Working Group, 1991). 
The following definitions are derived from this source. 
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HIV-1 associated dementia complex. Also referred to as HIV-1 
associated myelopathy, and consistent with the earlier definitions of 
HIV encepalopathy, this complex is somewhat more elaborate than the 
earlier definitions of AIDS dementia complex (Navia, Jordon, & Price, 
1986; Navia, Cho, & Petito, 1986). The essential feature of the 
complex is disabling cognitive impairment, typically accompanied by 
motor dysfunction and/or significant behavior change. The definition 
is consistent with DSM-III-R's definition of dementia, which requires 
that there be a memory deficit, accompanied by an impairment in 
abstract thinking, judgment, or the cognitive functions (i.e., aphasia, 
apraxia, agnosia, or constructional difficulty) . DSM-III-R defines 
dementia as characterized by "a loss of intellectual abilities of 
sufficient severity to interfere with social or occupational 
functioning." The Working Group's diagnostic criteria allow for the 
following distinctions: 
1. Those who have all three conditions--cognitive impairment, 
motor dysfunction, and behavioral change--are referred to as having 
HIV-1 associated dementia complex. 
2. Those with cognitive impairment and motor dysfunct ion, but 
without behavioral change, are referred to as having HIV-1 associated 
dementia complex (motor). 
3. Those with cognitive impairment behavioral change, but without 
motor dysfysfunction, are referred to as having HIV-1 associated 
dementia complex (behavior). 
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HIV-1 associated minor cognitive/motor disorder. Somewhat less 
severe than HIV-1 associated dementia complex, this disorder does not 
involve fundamental disruption of life function. When a seropositive 
individual has cognitive impairment of unknown etiology, but is not 
impaired to the degree required for the dementia diagnosis, this is the 
appropriate diagnosis. 
Additionally, the following working definitions will be employed 
in this study 
Styles of Coping. These will be assessed with the eight basic 
coping scales of the Mil lon Behavioral Health Inventory (MBHI) (Millon, 
Green, & Meagher, 1982). These coping styles are: introversive, 
inhibited, cooperative, sociable, confident, forceful, respectful, and 
sensitive. 
Psychogenic attitudes. These attitudes, which are essentially 
measures of stress, will be assessed with the six psychogenic attitudes 
scales of the MBHI: chronic tension, recent stress, premorbid 
pessimism, future despair, social alienation, and somatic anxiety. 
Psychosomatic correlates. These will be assessed with the three 
psychosomatic correlates scales of the MBHI: allergic inclination, 
gastrointestinal susceptibility, and cardiovascular tendency. 
Depression. Depression will be assessed with the Beck Depression 
Inventory. 
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CHAPTER II
REVIEW OF THE LITERATURE 
Chapter Overview 
This chapter reviews relevant literature in several interrelated 
areas, organized from the general to the specific. The first section 
deals with some of the most important research on coping with stress, 
with an emphasis on cognitive theories of coping. This general section 
provides relevant background for further exploration of coping with 
psychological stress by PWAs. 
The remainder of the chapter includes a review and critique of the 
existing body of research on the psychological impact of HIV infection. 
This includes a specific discussion of the psychological correlates of 
HIV infection and AIDS. The following section deals with the potential 
relationship between psychosocial variables and immune system 
functioning. The final section of the chapter briefly discusses the 
effects of HIV on cognitive functioning and the central nervous system. 
Coping with Stress 
Empirical research on adaptation to psychological stress was first 
conducted by the military during World War II to better understand how 
soldiers functioned under combat conditions. Psychologists had 
observed that brutal conditions (e.g., combat, concentration camps, 
natural disasters) led to breakdowns in the psychological functioning 
of some individuals, while others seemed to find ways to cope with the 
stress. Explaining the sources of these utterly different outcomes 
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could obviously be important in identifying the factors which would 
predict the best strategies for coping with situations of extreme 
stress. 
Individual interactions with (and attempts to manage) the 
surrounding environment have long been a concern of psychologists with 
diverse theoretical orientations. Not surprisingly, the theoretical 
explanations differ considerably. Psychoanalytic theories and ego 
psychology use the concept of conflict resolution to explain those ego 
processes which mediate between the person's impulses and the 
constraints of external reality. Developmental psychology focuses on 
the accumulation of coping abilities and resources over the life span 
as providing individuals with the ability to handle problems during 
each stage of the life cycle. Evolutionary and behavioral approaches 
emphasize the problem-solving aspects of coping to explain how 
individuals cope with problems they encounter (Moos & Billings, 1982). 
At one level, coping is a dynamic cognitive process which occurs 
in the interaction of individual with environment. However, coping 
also involves psychological, physiological, behavioral, and social 
components (Lazarus & Folkman, 1984; Menaghan, 1983). Selye observed 
that exposure to a stressor may be followed by physical and chemical 
changes in the body. Prolonged psychological and emotional stressors 
may be translated into physical illness, and physical coping involves 
both voluntary and involuntary changes in the body to manage the 
effects of stress (Selye, 1956, 1974). Behavioral coping occurs when 
individuals engage in specific, conscious behaviors to manage stress. 
Examples include relaxation exercises and specific tasks intended to 
improve the situation (Lazarus & Folkman, 1984). 
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Perhaps the most comprehensive and useful theoretical framework is 
that provided by the cognitive theories pioneered by Dr. Richard 
Lazarus and his colleagues at the University of California at Berkeley 
(Lazarus, 1981, 1982; Lazarus, Averill, & Opton, 1974). Their approach 
is based on individual level-assessment of events and the ability to 
cope effectively. Coping was originally seen as a problem- solving 
effort which occurs when an individual faces stressors that are 
directly related to his or her welfare and which are taxing to the 
individual's adaptive ability (Lazarus et al., 1974). 
The recognition that there is considerable individual variation in 
response to stress was an important factor in the development of 
cognitive theories of stress (Holroyd & Lazarus, 1982). These theories 
begin with the assumption that thinking and conscious reasoning have an 
effect on emotions, physical reactions, and behavior. At the most 
basic level, such cognitive theories are based on the observation that 
what differentiates human beings from other animals is their possession 
of language skills and their ability to think, reason, and solve 
problems. 
The occurrence of stressors, individual appraisals, and the 
adoption of specific coping behaviors and strategies should be seen as 
a dynamic process. Only when an event is appraised as representing a 
threat does coping occur. Both the original appraisal of an event as 
threatening or nonthreatening and the specific coping behavior chosen 
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are a function of beliefs and experiences over the course of an 
individual's life span. 
The primary dimensions of cognitive coping include coping styles 
(generalized attitudes, values, and skills), appraisals (intrapsychic 
evaluations of events), and coping behaviors such as problem solving or 
palliative adjustments of emotional reactions. Most researchers have 
incorporated these basic dimensions into their conceptual frameworks, 
although the terminology may differ from study to study. 
Lazarus' (1981) cognitive-based approach was influenced by the 
clinical Gestalt methods and phenomenological processes. These 
theories seek to explain individual variation by focusing on cognitive 
processes as shaping emotions. What a person thinks is shaped by 
beliefs, values, commitments, skills, and physical constitution. These 
become part of a dynamic transactional process among the individual, 
the environment, and particular events or situations. The individual's 
views come into play at the point of appraisal, and influence the 
original decision as to whether an event is important in the specific 
context, and thus whether it is necessary to generate a coping effort. 
Appraisals. By definition, coping begins as the reaction to an 
event (Fleishman, 1984). However, it is not a reaction to the event 
itself, but rather to the individual's perception of that event. 
Individuals perceive an event as having meaning for their well-being, 
an intrapsychic cognitive process known as primary appraisal. In order 
for persons to make satisfactory adaptations, they must be able to 
distinguish between benign and harmful stimuli or events (Lazarus, 
1982). If the primary appraisal is that the event is irrelevant to the 
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individual, no more mental energy will be expended. However, if the 
event has some potential meaning to the individual's welfare, the 
preliminary appraisal becomes a primary factor in det e· ~ining if it is 
potentially harmful or challenging (Lazarus et al., 1974). 
Events appraised as being potentially harmful or threatening 
receive a secondary appraisal, 1n which alternatives for managing the 
event and resources available are weighed and balanced. An individual 
will make several ifferent appraisals of events. When an event has 
been evaluated as being significant to the person's well-being it will 
be reconsidered a number of times. Secondary appraisals represent an 
opportunity for individuals to undertake active problem solving or to 
reappraise the event as not being threatening. These reappraisals may 
lead individuals to change the meanings which they attribute to the 
event (Lazarus & Folkman, 1984). Situations which are perceived as 
changeable often lead to positive reappraisals and renewed coping 
efforts (e.g., new problem-solving efforts) which may lead to more 
sa tisfactory outcomes. 
Personal experiences, and especially past experience with 
stressful situations, are important in determining outcome as well. 
Individuals who have had successful coping experiences in the past are 
likely to acquire feelings of personal efficacy, greater self-esteem, 
and self-confidence (Fleischman, 1984). In contrast, individuals who 
have had negative experiences are likely to feel less competent to deal 
with the stressor (Lazarus & Folkman, 1984). 
Resources. Each individual has a specific set of resources 
available for use as coping strategies. Resources include coping 
skills, beliefs, commitments, and values. These resources provide 
motivation and direction for coping activities. Coping behaviors are 
also situation-specific. The selection of one response over another 
depends on the situation and the person's coping resources. 
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Coping responses. Following an appraisal of any event as 
representing a threat, individuals will initiate coping responses to 
manage the event. Two primary modes of coping responses, emotion-
focused and problem-solving, may be distinguished (Lazarus, 1981). 
Each individual develops a coping style, shaped by patterns of 
behaviors and experience over the life span. Coping responses take 
many forms, and may include direct involvement of other persons or the 
use of their assets in managing stressful situations. 
Coping outcomes. Stressful events are of varying length, and the 
evaluation of the outcome of particular coping behaviors is 
problematic. Lazarus and Folkman (1984) categorized coping outcomes as 
either satisfactory or unsatisfactory based on self-reports. Events 
with satisfactory outcomes were frequently associated with changeable 
situations, positive reappraisals, and higher levels of planful problem 
solving. Events with unsatisfactory outcomes are typically situations 
perceived as unchangeable or involved a loss of respect for someone 
else. 
Coping, then, can be conceptualized as efforts to manage 
environmental stresses and/or to regulate the emotions aroused by the 
stress; these efforts may be both action-oriented and intrapsychic. 
Positive coping strategies such as information seeking appear to have a 
positive influence on adjustment. Information seeking may be seen as 
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representing an active, presumably instrumental, confrontative approach 
to illness, and thus linked to decreased negative affect (Felton & 
Revenson, 1984). In contrast, wish-fulfilling fantasy represents an 
avoidant strategy of diverting attention from the reality at hand; 
thus, it is an indicator of poor adjustment. 
The Psychological Impact of HIV 
Psychological adaptation to any life-threatening illness is a 
function of variation across three distinct dimensions (Holland, 1982): 
medical factors (symptoms, course of the disease, complications); 
psychological variables (especially coping skills and social support); 
and sociocultural milieu (the key variable being degree of social 
stigma experienced). Given the fact that the consequences of HIV 
infection are so unrelenting and grim, it is not surprising that most 
infected individuals experience a great deal of distress, anxiety, and 
depression. The HIV test itself is anxiety-producing and has 
tremendous psychological implications (Ostrow, 1985). Individuals are 
likely to react to a positive HIV test with feelings of helplessness 
and depression. 
Persons with AIDS (PWAs), particularly gay males, are likely to 
suffer from social isolation and stigmatization at the very time when 
they most need increased levels of social support. They may have close 
friends who are HIV-positive or who have AIDS, and are likely to 
experience continual grief combined with deep-seated anxiety about 
their own fate (Ostrow, 1986). It is not surprising that the feelings 
of distress and anxiety often develop into clinical syndromes such as 
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generalized anxiety disorder or major depressiv e disorder (Rubinow, 
Berrettini, Brouwers, & Lane, 1988). 
Coates, Temoshok, and Mandel (1984) focused on the relationship 
between biological and psychosocial variables in the development of 
AIDS. They pointed out that there are significant psychosocial 
determinants of both health-promoting and health-damaging behaviors, 
and that the way in which individuals cope with AIDS may be a crucial 
independent variable for research. 
Some researchers have studied the effects of disruption of the 
social environment on immune system functioning. For the individual 
wit h AIDS, one of the primary disruptions is likely to be the death of 
friends and the process of grief and bereavement itself. There is a 
clear relationship between the loss of a spouse and immune system 
functioning (Schleifer, Keller, Camerino, Thornton, & Stein, 1983). 
Others have demonstrated a correlation between loneliness and social 
isolation and immune response (Kielcolt-Glaser et al., 1984). 
As the disease progresses, social support becomes increasingly 
important. The PWA is likely to experience weakness, frequent 
infections, anorexia, fever, and myalgias. In the latter phases, 
frequent infections (particularly pneumonia) are likely to require 
repeated hospitalizations. Neurological complications (impaired 
function) are common, often manifesting as forgetfulness and inability 
to concentrate. 
The typical pattern experienced by the seropositive individual 
involves a normal stress response at the time of diagnosis, 
characterized by disbelief, numbness, and denial. This is followed by 
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anger, acute turmoil, and disruptive feelings of anxiety. In the case 
of anxiety, the most common symptoms include panic attacks, agitation, 
insomnia, tension, and tachycardia. 
Perry, Jacobsberg, Fishman, and Weiler (1990) studied the 
emotional impact of HIV antibody testing on 218 subjects undergoing 
testing (179 seronegative and 39 seropositive), both before and after 
test results were disclosed. The testing was accompanied by extensive 
counseling, at both pretest and posttest. Subjects were given the 
Hamilton Depression Scale, Beck Depression Inventory, and Brief Symptom 
Inventory. Results showed that the degree of psychological distress 
declined significantly among the seronegative subjects after learning 
the results of the antibody testing. Contrary to expectations, 
seropositive subjects did not demonstrate an increased level of 
psychological distress after learning the results. 
Rabkin, Williams, Remien, and Goetz (1991) studied the impact of 
psychiatric disorders, psychological distress, and psychosocial 
stressors on the course of HIV in a sample of 124 seropositive 
homosexual men. Subjects were assessed at baseline and at 6-month 
follow-up, with data collected including the Hamilton Depression Scale 
and the Brief Symptom Inventory. No consistent pattern of correlation 
was found between depression and psychological distress and immune 
status. 
Frigo et al. (1986) studied a group of HIV-positive individuals, 
and found that there were "significant adverse reactions" in 48% of 
their sample. Typical reactions included depression, anxiety, and 
preoccupation with AIDS. An additional 10% of their subjects were 
found to experience "serious difficulty" in coping with day-to-day 
life. 
The individual who moves from HIV-positive status to the 
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symptomatic phase of the illness is likely to experience psychological 
distress. The PWA who experiences serious opportunistic infections for 
the first time will inevitably experience high levels of stress as a 
result. Trass, Holland, and Wetzler (1985) compared 89 gay males with 
AIDS, 39 with AIDS-Related Complex (ARC), and 149 asymptomatic 
patients. They found that the men who had developed ARC experienced as 
equally high levels of general and AIDS-specific stress as the AIDS 
patients. 
The progression of AIDS may be seen in terms of models of reaction 
to the stress involved in any life-threatening illness. 
Initial crisis. During this phase of the illness, the typical 
reaction pattern involves an acute response of denial, alternating with 
periods of intense anxiety (Horowitz, 1973). Some patients may engage 
in such complete denial that they ignore medical advice or continue to 
engage in further high-risk sexual behavior. Most AIDS patients 
demonstrate P~otional reactions involving shock, denial, guilt, anger, 
and fear (Nichols, 1985). 
The initial crisis is exacerbated by the tremendous social stigma 
attached to the HIV diagnosis. The diagnosis may bring with it 
substantial disruption of the individual's social support networks. At 
the same time, the individual may suddenly find himself in a position 
where disclosure of such issues as sexual orientation and drug usage 
may become necessary. 
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Transitional state. The transitional state begins when the 
init al denial begins to recede, replaced by alternating states of 
ange·, guilt, anxiety, and self-pity (Nichols, 1985). This period is 
char ,cterized by a great deal of distress and confusion. Typical 
dist ·essing events include social ostracization and estrangement from 
fami ies, leading to loss of self-esteem and even suicidal attempts. 
The :ransitional state may also be made more difficult by the loss of 
econ1mic resources as the individual becomes less able to hold down a 
job. 
Deficiency state (acceptance). According to Nichols (1985), a new 
and ,ore stable identity may finally develop during this state. The 
indi , idual learns to realistically accept the limitations that 
acc~pany AIDS, and make adjustments in his lifestyle that allows him 
to f1nction as optimally as possible. 
Trass and Hirsch (1988) cite several serious consequences that are 
typi :ally faced by PWAs, all likely to be extremely stressful. For 
exarr:>le, they may experience job loss, eviction, denial or termination 
of i1surance and public services (police, sanitation, fear of being 
ref~ed burial), delays in getting needed health care, and generalized 
anxBty. They may also fear that health care workers will exercise 
exc6sive infection control precautions, and that physicians and nurses 
mayJe insensitive to their psychological needs. It should also be 
notd that most PWAs reach a point at which they must exhaust all of 
the r financial resources in order to survive. In many cases, their 
ins~ance expires (or is cancelled), and they find themselves at the 
mer~ of the American health care system. According to Dane (1989), 
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PWAs may find themselves in a state of crisis as a result of (a) a 
hazardous event, (b) a vulnerable state, or (c) an inability to respond 
to stress with adequate coping mechanisms. 
Insufficient attention has been given to the massive experience of 
grief, particularly for PWAs living in major urban centers with large 
gay populations. Such individuals are likely to undergo a series of 
progressive bereavements , as they lose multiple friends to the disease. 
In many cases this is equivalent to destroying their primary social 
support network. 
Any such grief is often accompanied by profound sadness, numbing, 
wi hdrawal, and "vegetative " depressive symptoms, as well as much 
higher rates of alcohol and substance abuse (maladaptive coping 
mechanisms). Perhaps most fundamentally, the person diagnosed with 
AIDS must come to grips with the reality that he is going to die. 
According to Kubler-Ross (1969), the primary psychological task to be 
at tained is to come to a personal adaptation with this new and 
di 5turbing reality. Kubler-Ross characterized this process as 
in olving a set of overlapping bereavement processes. This cycle 
ty~ically begins with denial, which is followed by anger, bargaining, 
de~ression, and eventually an acceptance of the situation. There is a 
sinilarity here with the anticipatory grief reaction that occurs among 
parents and families of other types of dying patients. 
The Relationship Between Psychosocial Variables 
and Immune System Functioning 
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Various researchers have explored the relationship between levels 
of depression and immune system function. Schleifer, Keller, and 
Meyerson (1984) found that patients hospitalized with major depressive 
disorder had impaired lymphocyte response to mitogens and lowered CD4 
cell counts. This was followed up with a study of ambulatory patients 
with major depressive disorder. When compared with groups of matched 
controls and inpatient schizophrenia, CD4 cell counts were found to be 
significantly lower among the depressed patients. 
Solomon and Temoshok (1987) conducted one of the first studies to 
systematically examine the effects of psychosocial variables on immune 
function in persons with AIDS and ARC. They found that individuals who 
were psychologically distressed (defined as high levels of anxiety, 
hopelessness, and depressed mood state) were more likely to have 
impaired immune response as measured by CD4 and CD8 :e ll counts. 
In a follow-up study, the same group of researchers (Solomon, 
Temoshok, O'Leary, & Zich, 1987) conducted in-depth psychosocial 
interviews with AIDS patients over a 5-week period, while collecting 
data on immune function during each of the 5 weeks. Results identified 
several correlates of enhanced T-cell functioning: higher levels of 
tension and anxiety, lower levels of depression, and lower levels of 
hostility. 
Temoshok, Zich, Solomon, and Stites (1987) studied the 
relationship among psychological, immunological, and neuropsychological 
variables in a sample of 100 seropositive gay men. Data on absolute 
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number of CD4 (helper) cells and psychological variables were collected 
at both baseline and 6-months follow-up. Results showed that measures 
of tension/anxiety, trait/anxiety, anger/hostility, and loneliness were 
all associated with impaired T-cell counts. These researchers stressed 
that the precise relationship between psychosocial variables and immune 
system functioning may vary substantially depending on the stage of the 
illness. 
There is an emerging consensus that everyday stressful events can 
have a significant impact on the immune system (Kielcolt-Glaser & 
Glaser, 1988). The effect of stress on immune function may be 
associated with actual changes in cellular immunity. Glaser and 
Kielcolt-Glaser (1988) argued that this effect persists even when the 
effects of age, loss of sleep, smoking, drinking, and caffeine intake 
are controlled for. 
Dorian and Garfinkel (1987) studied immune system function in a 
comparative study of psychiatry residents undergoing an oral fellowship 
examination and a control group of similar residents not taking the 
examination. They found that there were considerable differences in 
both B-cell and T-cell counts during the weeks leading up to the exam. 
Similar studies were undertaken by Glaser, Kielcolt-Glaser, Speicher, 
and Holliday (1985), who observed a changing pattern of immune system 
functioning in a sample of medical students tracked through a semester 
of medical school. Immune system functioning was found to be impaired 
during examination periods. In a related study, researchers examined 
immunological changes in blood samples drawn from medical students 
during examinations as compared to a baseline period one month earlier 
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(Glaser, Rice, Speicher, Stout, & Kielcolt-Glaser, 1986). Results 
showed that the blood samples drawn during the examination period had 
much lower natural killer (NK) cell activity. A related finding was 
that students who were more socially isolated showed greater degrees of 
immunosuppression. 
Chuang, Devins, Hunsley, and Gill (1989) studied levels of 
psychological distress in 65 HIV positive gay and bisexual men. They 
found that all the subjects demonstrated higher than expected levels of 
psychosocial distress, defined as depression, mood swings , anxiety, 
negative affect, and suicidal ideation. Asymptomatic individuals and 
individuals with AIDS-Related Complex were found to be more distressed 
than persons with full-blown AIDS. 
Temoshok et al. (1987) conducted one of the first in-depth 
psychoimmunologic studies of PWAs. Although their sample was quite 
small (N = 12), they found that there were striking correlations 
between psychological outcomes and immune system functioning. 
Temoshok (1988) conducted a psychoimmunologic study of 55 AIDS/ARC 
subjects, collecting data on a range of variables measuring overall 
dysphoric affect. Subjects completed the psychosocial self-report 
measures within 2 to 8 weeks after diagnosis. The dependent variable 
was assessed using standard measures for anxiety, mood state, and 
hopelessness. Results showed that overall dysphoric affect was 
positively correlated with overall white blood cell counts. 
It is still not clear exactly when the effects of psychological 
variables make themselves felt; in part, this can be attributed to the 
lack of clear understanding of the precise pathogenisis of CD4 cell 
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destruction by HIV (Gorman & Kertzner, 1990). Some researchers have 
suggested that the existence of previous impairment of the immune 
system may be a precondition for the psychological variables to have a 
further impact (Schlieter, Keller, & Bond, 1989). 
Several recent studies have also clarified the relationship 
between psychosocial variables and immune system functioning. 
Particularly noteworthy is the work of Kemeny et al. (1992) and Burack 
et al. (1992). 
Kemeny et al. (1992) studied the relationship among bereavement, 
depressed mood, and immunologic patterns. While they found no effect 
of bereavement, they reported that more depressed mood was positively 
associated with fewer CD4 cells. 
Recently, Burack et al. (1992) reported an important set of 
findings at the Eighth International Conference on AIDS in Amsterdam. 
They looked specifically at the correlation between depressive 
symptomatology and CD4 counts in a sample drawn from the San Francisco 
Men's Health Study. They studied 308 HIV seropositive subjects in a 6-
year prospective study (following subjects from 1985 to 1991). 
Individuals who were depressed, as measured with the Center for 
Epidemiological Studies Depression Scale, showed a higher 4-year 
mortality rate than less-depressed individuals. The researchers 
concluded that HIV seropositive patients meeting the criterion for 
clinical depression experienced a faster rate of CD4 cell depletion, as 
well as the observed higher mortality rate. 
Burack pointed out in a press release issued at the conference 
that the mechanisms through which depression affects immune system 
functioning are not clear. It is possible that depressed persons may 
be less compliant, or less likely to take all possible steps to 
maintain their immune system functioning. Alternatively, they might 
also be more likely to continue engaging in high-risk behaviors. 
The Effects of HIV on Cognitive Functioning 
and the Central Nervous System 
Effects on Cognitive Functioning 
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Recent research has suggested that subtle types of cognitive 
dysfunction may be present even in the earliest stages of HIV infection 
(Kovner et al., 1989). Various researchers have reported that AIDS 
patients suffer from memory impairment (Levy, Fernandez, Holmes, Gagen 
& Pirozzolo, 1987) and psychomotor slowing (Saykin et al., 1987). 
However, it is not entirely clear whether early cognitive 
dysfunction results from the physiological effects of the HIV virus on 
brain tissue, or whether it is a psychophysiological response by the 
individual to the knowledge of the life-threatening nature of the 
illness (Rubinow et al., 1988). 
There are also direct organic effects on the brain, as evidenced 
by studies demonstrating the presence of HIV-infected giant cells 
(Koenig et al., 1986) and HIV receptors (Levy, Shimabururo, & Hollander 
1985) in the brain. Other researchers have found substantial evidence 
of cognitive impairment in AIDS patients, despite the lack of 
physiological evidence of opportunistic infections having directly 
affected the central nervous system of the brain (Joffe, Rubinow, & 
Squillace, 1986). In other words, the effects of HIV on cognition and 
38 
personality function may be significant even in asymptomatic 
individuals. 
Joffe et al. (1986) compared cognitive functioning between a group 
of 13 AIDS patients (without overt CNS dynfunction) and a matched group 
of 10 age- and education-matched gay male controls. Findings were that 
the AIDS patients demonstrated significant impairment in performance on 
the WAIS (full-scale IQ, verbal IQ, vocabulary subtest, similarities 
subtest, and the symbol subtest), the Halstead Category Test, and the 
Trail Making Test. However, the researchers did not have serological 
test results available for the control group, and thus were not able to 
control for possible undiagnosed HIV infection. 
Rubinow et al. (1988) conducted a follow-up study, comparing a 
group of 13 medication-free AIDS patients, an HIV-positive control 
group (N = 9), a chronic illness control group with chronic active 
hepatitis (N = 9), and a group of health controls (N = 6) . Subjects 
were given a battery of neuropsychological tests, including the WAIS, 
the Halstead Category Test, Trail Making Test (trail B), and 
cancellation tasks. Consistent with the earlier findings of Joffe et 
al. (1986), the AIDS patients were found to score significantly lower 
on all of the cognitive tasks . 
Kovner et al. (1989) conducted a prospective study of 26 HIV-
positive subjects who were categorized (per CDC criteria) as having 
AIDS (group IVC), ARC (IVA), or seropositive for HIV (group II). 
Subjects were given a test battery of 23 measures tapping 
neuropsychological processes (cognitive, attentional, and personality). 
The objective of the study was to evaluate whether cognitive/ 
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neuropsychological impairment could be explained as a function of mood 
and attentional changes accompanying the HIV diagnosis. Results showed 
that the cognitive impairments found in HIV-infected ambulatory 
subjects could not be explained by variation in affective and 
attentional factors. 
Ayers, Abrams, Newell, and Fried ric h (1987) evaluated the 
differences on the Luria-Nebraska Neuropsychological Battery, the MMPI, 
and the Beck Depression Inventory in a sample of 60 males classified by 
level of infection. Results showed significant impairments in writing, 
memory, tactile, and intellectual function for subjects at all levels 
of infection. The researchers pointed out that some degree of 
impairment appears to exist even from the early (asymptomatic) stage, 
and that early intervention is essential. 
Praus, Brown, Rundell, and Paolucci (1990) examined the 
correlations between anxiety and depression and immune system function 
in a sample of 98 subjects undergoing HIV antibody testing. Almost all 
(95%) of the subjects tested seronegative. Results showed significant 
inverse correlations between levels of depression (measured by the 
Hamilton Depression Scale) and CSF nucleated cell counts and protein 
levels. In other words, there was a relationship between high levels 
and depression and impaired immune system functioning. 
Effects on the Central Nervous System 
The effects of HIV on the central nervous system have been well 
established (Perry, Belsky-Barr, Barr, & Jacobsberg, 1989). One of the 
more common CNS complications is nonfocal encephalopathy, with dementia 
as the dominant feature (Snider et al., 1984). The symptoms of 
40 
encep1alopathy are quite similar to those of clinical depression, at 
least in the early stages (Holland & Tross, 1985). The typical initial 
symptoms are forgetfulness and inability to concentrate, followed by 
psych,motor retardation, apathy, withdrawal, and loss of libido. Over 
sever il months, further symptoms include confusion, disorientation, 
seizu -es, and profound dementia. 
none study of 180 patients receiving full neurological 
exami1ations during a 3-year period, nine were initially diagnosed with 
demen:ia. By the end of the period, over half had developed 
signi -icant cognitive dysfunction (Tross et al., 1985). The rate of 
progr!ssion of the symptoms shows considerable variation, ranging from 
a fewweeks to several months after onset. 
Chapter Summary 
·he first section of this chapter discussed the basic coping model 
which provides a key part of the theoretical framework for the 
disse -tation. The emphasis was on the cognitive approach to stress and 
copinJ developed by Dr. Richard Lazarus. The second section dealt with 
the p;ychological impact of HIV and AIDS. These effects are 
poten:ially devastating, ranging from depression to impaired self-
estee n to suicidal ideation. 
·his was followed by a review of some of the recent empirical 
studi 1s that have been done on the relationship between psychosocial 
varia>les and immune system functioning. The literature reviewed in 
this ;ection of the chapter builds on the literature from 
psych,neuroimmunology reviewed as part of the "Theoretical Framework" 
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presented in the first chapter. The final section of this chapter 
discusses the effects of AIDS on both cognitive functioning and on the 
central nervous system. 
The following chapter presents the research methods utilized in 
the current st - Jy of the relationship between coping styles, stress, 
and immune system functioning. 
CHAPTER I I I 
METHODOLOGY 
Restatement of the Problem 
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Persons with AIDS (PWAs) are vulnerable to a variety of 
psychological difficulties, ranging from the expected anxiety to 
clinical depression and dementia. While many of these disorders, 
particularly in the terminal stages, fall into the category of 
physiologically determined neuropsychological disorders, many other 
disorders are entirely psychological in nature. There is a growing 
body of research, particularly in the evolving field of 
psychoneuroimmunology, which suggests that psychological variables have 
a significant influence on immune system function. To the degree that 
there is such a relationship, the prevention and mediation of 
psychiatric disorders is important in limiting the degree of immune 
system breakdown. 
The current study, then, addressed the issue of the relationship 
between psychological well-being and immune function in a sample of 
seropositive males drawn from the patient population at the Veteran's 
Affairs Medical Center in West Los Angeles. 
Research Design 
In an "ideal" scenario, an experimental research study addressing 
this topic would systematically compare various groups of patients, 
including subjects who are seropositive but who have not been informed. 
This would allow the potential confounding effects of previous health 
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and the impact of the knowledge of diagnosis to be controlled for in 
the research design itself. This type of research design would be 
ethically questionable under American Psychological Association 
guidelines. In other words, the current research topic is a classic 
example of a situation where it was not practical or ethical to control 
the independent variable using experimental techniques such as random 
assignment to groups. 
Instead, the current study employed a quasi-experimental 
longitudinal design to assess the relationship between various 
psychological independent variables and immune system functioning, 
operationalized as CD4 counts, in a cohort of AIDS patients over a 24-
month time period. 
More specifically, the study involved the collection of a battery 
of psychological and neuropsychological instruments and CD4 data at 
baseline, as well as data on depression (collected at baseline and 
twelve months) and CD4 counts at 6-month intervals over a 2-year 
period. The study analyzed the effect of coping style, stress, and 
somatic symptoms (the MBHI measures), as well as the effects of 
baseline depression, on immune sytem functioning over the two-year 
period. 
Variables in the study design included: 
Dependent variable. Immune system functioning (CD4 cell counts), 
collected every six months over the 24-month time period. This is the 
most widely used indicator of immune system functioning in AIDS 
research. 
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The difficulties involved in analyzing time series data are 
summarized by Kerlinger (1973), who points out that: 
The statistical analysis of time measures is a special and 
troublesome problem; the usual tests of significance applied 
to time measures can yield spurious results. One reason is 
that such data tend to be highly variable ... in time data, 
individual and mean scores tend to move around a good bit. 
(p. 345) 
Given these difficulties inherent in collecting time series data, the 
focus was on evaluating the CD4 data at 6, 12, 18, and 24 months, while 
controlling for the baseline CD4 values. This is effectively the same 
as conceptualizing the dependent variable as the change in CD4 values 
from baseline to each of the subsequent time periods, or alternatively 
as the slope of changing CD4 values over time. However, by 
conceptualizing the model as predicting CD4 values while controlling 
for baseline values, t he statistical difficulties involved in analyzing 
change scores are addressed. 
The rationale for predicting CD4 cell counts is that such counts 
are widely treated in the AIDS literature as the primary indicator of 
adequate immune system functioning. The different types of immune 
system cells work together, with the CD4 cells regulating the immune 
response of the body, while the CDS cells and other immune cells 
actually fight off infected cells. In other words, the primary 
characteristic of the human immunodeficiency virus is the progressive 
depletion of CD4-bearing T-lymphocytes preceded by functional deficits 
in cell-mediated immunity. These immunologic defects are accompanied 
by clinical manifestations that are initially relatively minor, but as 
the immune dysfunction progresses, severe opportunistic infections or 
malignancies develop, fulfilling the established criteria for AIDS. 
Independent variables. Independent variables in the study 
included the first set of independent variables, derived from the 
Millon Behavioral Health Inventory (MBHI), which were: 
1. The eight basic MBHI coping styles: Introversive Style, 
Inhibited Style, Cooperative Style, Sociable Style, Confident Style, 
Forceful Style, Respectful Style, and Sensitive Style. 
2. The three MBHI psychosomatic correlates: Allergic 
Inclination, Gastrointestinal Susceptibility, and Cardiovascular 
Tendency. 
3. The six MBHI psychogenic attitudes scales, essentially 
indicators of stress: Chronic Tension, Recent Stress, Premorbid 
Pessimism, Future Despair, Social Alienation, and Somatic Anxiety. 
Additionally, the Beck Depression Inventory was utilized as an 
independent variable. 
Research Hypotheses 
Each research hypothesis was statistically evaluated at the Q < 
.05 level of significance. The primary statistical technique, 
discussed in more detail below, was analysis of covariance with the 
baseline CD4 value as the covariate controlled for in the model. 
The first eight hypotheses refer to the relationship between the 
measures of coping style provided by the MBHI and immune system 
functioning. As discussed in the "Theoretical Framework" section in 
Chapter I, these scales are based explicitly on Millon's theory of 
personality and psychopathology. Higher scores on each subscale 
represent higher scores on that particular type of maladaptive coping. 
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While there are no specific cutpoints defining psychopathology on any 
of the dimensions, higher scores can be assumed to reflect greater 
degrees of that particular style of maladaptive coping. 
Each of the hypotheses is stated in null form. 
Hypothesis #1. Subjects who score higher on Introversive Coping 
at Baseline wi l l not differ on CD4 counts at 6 months, 12 months, 18 
months, and 24 months from subjects with lower Introversive Coping 
scores at Baseline, while controlling for the effects of Baseline CD4 
counts. 
Hypothesis #2. Subjects who score higher on Inhibited Coping at 
Baseline will not differ on CD4 counts at 6 months, 12 months, 18 
months, and 24 months from subjects with lower Inhibited Coping scores 
at Baseline, while controlling for the effects of Baseline CD4 counts. 
Hypothesis #3. Subjects who score higher on Cooperative Coping at 
Baseline will not differ on CD4 counts at 6 months, 12 months, 18 
months, and 24 months from subjects with lower Cooperative Coping 
scores at Baseline, while controlling for the effects of Baseline CD4 
counts . 
Hypothesis #4. Subjects who score higher on Sociable Coping at 
Baseline will not differ on CD4 counts at 6 months, 12 months, 18 
months, and 24 months from subjects with lower Sociable Coping scores 
at Baseline, while controlling for the effects of Baseline CD4 counts. 
Hypothesis #5. Subjects who score higher on Confident Coping at 
Baseline will not differ on CD4 counts at 6 months, 12 months, 18 
months, and 24 months from subjects with lower Confident Coping scores 
at Baseline, while controlling for the effects of Baseline CD4 counts. 
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Hypothesis #6. Subjects who score higher on Forceful Coping at 
Baseline will not differ on CD4 counts at 6 months, 12 months, 18 
months, and 24 months from subjects with lower Forceful Coping scores 
at Baseline, while controlling for the effects of Baseline CD4 counts. 
Hypothesis #7. Subjects who score higher on Respectful Coping at 
Baseline will not differ on CD4 counts at 6 months, 12 months, 18 
months, and 24 months from subjects with lower Respectful Coping scores 
at Baseline, while controlling for the effects of Baseline CD4 counts. 
Hypothesis #8. Subjects who score higher on Sensitive Coping at 
Baseline will not differ on CD4 counts at 6 months, 12 months, 18 
months, and 24 months from subjects with lower Sensitive Coping scores 
at Baseline, while controlling for the effects of Baseline CD4 counts. 
The next six hypotheses refer to the re lationship between the 
psychogenic attitudes scales of the MBHI, each measuring a different 
dimension of stress, and immune system functioning . 
Hypothesis #9. Subjects who score higher on Chronic Tension at 
Baseline will not differ on CD4 counts at 6 months, 12 months, 18 
months , and 24 months from subjects with lower Chronic Tension scores 
at Baseline, while controlling for the effects of Baseline CD4 counts. 
Hypothesis #10. Subjects who score higher on Recent Stress at 
Baseline will not differ on CD4 counts at 6 months, 12 months, 18 
months, and 24 months from subjects with lower Recent Stress scores at 
Baseline, while controlling for the effects of Baseline CD4 counts. 
Hypothesis #11. Subjects who score higher on Premorbid Pessimism 
at Baseline will not differ on CD4 counts at 6 months, 12 months, 18 
months, and 24 months from subjects with lower Premorbid Pessimism 
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scores at Baseline, while controlling for the effect s of Baseline CD4 
counts. 
Hypothesis #12. Subjects who score higher on Future Despair at 
Baseline will not differ on CD4 counts at 6 months, 12 months, 18 
months, and 24 months from subjects with lower Future Despair scores at 
Baseline, while controlling for the effects of Baseline CD4 counts. 
Hypothesis #13. Subjects who score higher on Social Alienation at 
Baseline will not differ on CD4 counts at 6 months, 12 months, 18 
months, and 24 months from subjects with lower Social Alienation scores 
at Baseline, while controlling for the effects of Baseline CD4 counts. 
Hypothesis #14. Subjects who score higher on Somatic Anxiety at 
Baseline will not differ on CD4 counts at 6 months, 12 months, 18 
months, and 24 months from subjects with lower Somatic Anxiety scores 
at Baseline, while controlling for the effects of Baseline CD4 counts. 
The next three hypotheses refer to the relationship between the 
psychosomatic correlate measures provided by the MBHI and immune system 
functioning. 
Hypothesis #15. Subjects who score higher on Allergic Inclination 
at Baseline will not differ on CD4 counts at 6 months, 12 months, 18 
months, and 24 months from subjects with lower Allergic Inclination 
scores at Baseline, while controlling for the effects of Baseline CD4 
counts. 
Hypothesis #16. Subjects who score higher on Gastrointestinal 
Susceptibility at Baseline will not differ on CD4 counts at 6 months, 
12 months, 18 months, and 24 months from subjects with lower 
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Gastrointestinal Susceptibility scores at baseline, while controlling 
for the effects of Baseline CD4 counts. 
Hypothesis #17. Subjects who score higher on Cardiovascular 
Tendency at Baseline will not differ on CD4 counts at 6 months, 12 
months, 18 months, and 24 months from subjects with lower 
Cardiovascular Tendency scores at baseline, while controlling for the 
effects of Baseline CD4 counts. 
The next hypothesis refers to the relationship between the Beck 
Depression Inventory and immune system functioning. 
Hypothesis #18. Subjects who score higher on Depression at 
Baseline will not differ on CD4 counts at 6 months, 12 months, 18 
months, and 24 months from subjects with lower Depression scores at 
baseline, while controlling for the effects of Baseline CD4 counts. 
The next hypothesis postulated that it is possible to predict the 
change in CD4 levels by utilizing all of the above independent 
variables in a multivariate framework. This multivariate hypothesis is 
also stated in null form. 
Hypothesis #19. CD4 levels at each time period after baseline (6 
months, 12 months, 18 months, and 24 months) cannot be predicted by a 
multivariate combination of the coping styles, the psychosomatic 
correlate scales, the psychogenic attitudes scales, and level of 
Depression, while controlling for the effects of Baseline CD4 counts. 
Procedures 
This study was conducted as a supplementary component of a 
Veterans Affairs-funded study being conducted at the West Los Angeles 
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Veterans Affairs Medical Center. The current study tapped into the 
existing patient population at the West Los Angeles Veterans Affairs 
Medical Center. 
All instruments were administered in an outpatient clinic setting 
on a one-on-one basis. All examiners were doctoral or post-doctoral 
students in the UCLA-Veterans Administration Neuropsychology program 
who had been thoroughly trained by qualified neuropsychologists in 
administering the instruments. 
CD4 and CD8 levels were obtained via laboratory analysis of blood 
samples obtained from the subjects. All blood samples were drawn by 
certified laboratory technicians employed by the Veterans Affairs 
Administration. Certain physiological tests were administered only to 
patients who had become symptomatic. These included a Magnetic 
Resonance Imaging (MRI), Computerized Tomography (CT) Scan, and/or a 
Positron Emission Tomography (PET) Scan. 
Subjects 
HIV Seropositive 
Subjects consisted of community-dwelling, self-identified gay or 
bisexual males or IV drug users enrolled in a longitudinal study of the 
psychological and neuropsychological effects of HIV infection. 
Subjects were enrolled from the VA outpatient immune deficiency clinic. 
All of the HIV positive subjects had been found to be HIV-1 
seropositive within the previous six months based on ELISA testing with 
Western blot confirmation. 
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There were 92 subjects diagnosed as HIV seropositive; of these 
subjects, baseline data were available for 79 subjects. Fifteen of the 
seropositive subjects had been diagnosed as having full-blown AIDS. 
The primary mode of transmission was homosexual contact, with only 
three HIV seropositive subjects indicating they had been infected via 
heterosexual contact or IV drugs. Over a third (37%) of the 
seropositive subjects were identified having abused alcohol at one 
point or another in their lives, with 40% having abused drugs. 
Substance abuse was defined based on clinical evaluation using DSM-III-
R criteria (305.00 for Alcohol Abuse and 305.90 for Substance Abuse, 
N.O.S.). 
A demographic profile of the seropositive subjects is shown in 
Table 2. Mean age was 42.1 years. Educational attainment was 
moderate, with 28.3% of seropositive subjects having only a high school 
diploma or less. Only 16.2% had a college degree or graduate work. 
More than half (58%) were employed, with 18. 5% being unemployed 
specifically due to HIV. Most of the subjects were white, although 
there was some minority representation. 
In the sample of seropositive patients, slightly less than a third 
(30%) of the seropositive subjects were taking AZT, an anti-retroviral 
agent that is thought to inhibit replication of HIV. The proportion of 
subjects taking AZT was much higher among those with full-blown AIDS 
(67%) than it was among those who were still asymptomatic (13%). A 
series of chi-square analyses was completed comparing AZT drug use to 
high and low groups for each hypothesis. Results showed no significant 
differences. 
Table 2 
Demographic Profile of Seropositive Subjects 
Variable 
Age 
20-30 
31-40 
41-50 
51-60 
61+ 
Education 
High School or Less 
Some College 
4-Year Degree 
Graduate Work 
Employment Status 
Working 
Unemployed 
Unemployed due to HIV 
Ethnicity 
White 
African American 
Latino 
Asian American 
Number 
12 
31 
33 
10 
6 
26 
40 
13 
13 
53 
22 
17 
74 
11 
5 
4 
Percentage 
13.0% 
33.7% 
35.9% 
10.9% 
6.5 % 
28.3% 
43.5% 
8.1 % 
8.1 % 
57.6% 
23.9% 
18.5% 
80.4% 
12.0% 
5.4% 
2.2 % 
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CD4 data were availabl e for a subsample of the HIV seropositive 
subjects, with the number of available data points declining for each 
"wave " of data collection. Descriptive statistics on the available CD4 
data are shown in Table 3. 
HIV Seroneqative 
A seronegative control group consisting of 29 gay males who had 
received a negative test result were included. Control group members 
were similar to the seropositive group on most background variables. 
However, they were somewhat more educated than the HIV-positive group 
Table 3 
Available CD4 Data and Study: Attrition 
CD4 Counts N Mean SD 
Mortality 
Rate Withdrawal 
Baseline 79 320.462 203.084 
6 Months 57 331.491 228.461 
12 Months 45 282.178 209.853 
18 Months 26 230.7 31 187.258 
24 Months 24 223.917 201. 801 21 10 
*Normal CD4 range is 800-1300 
(15.4 years versus 14.3 years) (Q < .05), more likely to be employed 
(attributable the the fact that the HIV- positive subjects were more 
likely to be on disability), and had le ss self-reported drug and 
alochol abuse. 
Instruments 
The Millon Behavioral Health Inventory: 
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Van Gorp and Cummings (1989) have pointed out that changes in mood 
and affect are commonly associated wi t h certain types of brain 
dysfunction regardless of age; in fact , during the early stages of some 
progressive conditions, changes in mood and affect may precede 
abnormalities in the cognitive sphere. This implies that it is 
important for clinicians and researchers to develop and apply 
appropriate measures of mood, affect, and personality designed 
specifically for--and validated on--individuals in whom brain disease 
is suspected. If it is necessary to rel y on traditional personality 
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instruments (i.e., instruments validated on normal populations), the 
results must be interpreted with caution. 
The MBHI is a 150-item inventory that yields 20 scores, as well as 
a three-item validity scale. The MBHI is one of the few instruments 
designed "specifically with physically ill patients and medical-
behavioral decision-making issues in mind" (Millon et al., 1981, p. 
163). 
Basic coping styles. The eight basic coping styles that comprise 
the MBHI are derived from Millon's (1969) theory of personality. 
1. Introversive Style (32 items) 
2. Inhibited Style (43 items) 
3. Cooperative Style (33 items) 
4. Sociable Style (40 items) 
5. Confident Style (33 items) 
6. Forceful Style (33 items) 
7. Respectful Style (42 items) 
8. Sensitive Style (48 items) 
Psychogenic attitudes scales. Six psychogenic attitudes scales 
were developed to reflect psychosocial stressors identified in the 
literature as likely to be predictive of physical illness. These 
reflect the respondents' perceptions of present and future stressors. 
A. Chronic Tension (29 items) 
B. Recent Stress (20 items) 
C. Premorbid Pessimism (40 items) 
D. Future Despair (38 items) 
E. Social Alienation (33 items) 
F. Somatic Anxiety (34 items) 
Psychosomatic correlates scales. Three psychosomatic correlates 
scales were developed: 
MM. Allergic Inclination (34 items) 
NN. Gastrointestinal Susceptibility (27 items) 
00. Cardiovascular Tendency (38 items) 
Prognostic indices scales. An additional three scales measuring 
prognosis were developed: 
PP. Pain Treatment Responsivity (42 items) 
QQ. Life Threat Reactivity (42 items) 
RR. Emotional Vulnerability (12 items) 
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Development of the MBHI. Initially, a pool of over 1,000 items 
was identified. Items for the pool were identified based on items from 
other instruments, abnormal and personality texts, and analysis of 
personality dimensions. Items were developed with the objective of 
covering the full range of possible coping styles and personality 
characteristics. Items were balanced so that approximately half were 
phrased in a positive direction, and half in a negative direction. 
This pool of items was then administered to several samples in 
medical settings, with the results then analyzed to reduce the pool of 
items to those that discriminated patients on the role played by 
psychosocial factors in their illnesses. This analysis was 
supplemented with item-scale correlation analysis and content analysis 
of the items. Items were dropped that were determined to be too 
complicated, showed desirability bias, or lacked clarity in phrasing. 
The results of these statistical and substantive analyses were used in 
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reducing the pool to 64 items (for eight basic coping styles), 83 items 
(for six Psychogenic Attitude scales), and 3 validation items. 
Millon et al. (1979) assessed the reliability characteristics of 
the MBHI, and found that Kuder-Richardson reliability coefficie nts (the 
KR-20 version of coefficient alpha for internal consistency) ranged 
from .66 to .90 for the MBHI scales. They also conducted a test-
retest, with 89 patients tested at intervals ranging from 1 to 8 
months. They found test- r etes t coefficients for the scales ranging 
from .72 to .93 (median test-retest coefficient of .83). 
Murphy, Sperr, and Sperr (1986) conducted a validation study in 
which they assessed the predictive validity of the MMPI and the MBHI 
simultaneously. Utilizing a sample of patients presenting with chronic 
pain, the researchers assessed the perceptions of medical 
psychologists, nonmedical psychologists, and physicians regarding the 
relative usefulness of the two instruments in predicting outcome. The 
practitioners were asked to rate the instruments on ten dimensions of 
clinical utility; they expressed a preference for the MBHI on nine of 
the ten dimensions. 
Sweet, Breuer, Hazelwood, Toye, and Pawl (1985) assessed the 
validity of the MBHI by correlating the MBHI subscales with selected 
MMPI subscales and the Beck Depression Inventory. Their findings were 
somewhat inconsistent. Correlations between the MBHI and the 
~ypochondriasis (Hs) and Hysteria (Hy) MMPI scales were low; this was 
contrary to expectations, in that these MMPI scales are generally 
thought to reflect health-related concerns and inadequate adjustment to 
chronic pain or illness. However, findings did show that the MBHI 
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subscales tended to be correlated with MMPI scales reflecting emotional 
distress (Depression, Psychasthenia) or psychopathology (Psychopathic 
Deviate, Paranoia, Schizophrenia, Social Isolation). 
Weisberg and Page (1988) conducted a study of 42 dialysis 
patients, and found that the MBHI Coping Style and Psychogenic Attitude 
Prognostic scales were highly predictive of patient welfare and 
satisfaction. They also found that the MBHI scales had considerable 
predictive validity in terms of differentiating patients having 
dialysis in the home as compared to the hospital setting. That is, 
patients with fewer pathological coping styles were found to be more 
likely to obtain their dialysis treatment in the home setting. 
Beck Depression Inventory 
The Beck Depression Inventory (BDI), which was developed 
originally to assess the presence and severity of a depressive syndrome 
in adults (Beck, Ward, Mendolsson, Mock, & Erbaugh, 1961), is a paper 
and pencil, self-rating scale that taps various components of 
depression: 
psychomotor. 
affective, cognitive, motivational, vegetative, and 
Both the BDI's reliability and validity are 
well-established, and it has been used successful ly both with normal 
and patient populations. 
The Beck Depression Inventory is a 21-item test, on which scores 
can range from 0-63. Higher scores represent higher levels of 
depression. It consists of 21 ite ms; each answered on a continuum of 
severity ("I do not feel sad" versus "I am so sad or so unhappy that I 
can't stand it"). Seven of the 21 items reflect physical health or 
fatigue. 
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On each of the 21 items, the subject is presented with four 
choices and is asked to pick out the one statement in each group that 
best describes the way he or she feels at the present time. It is 
possible for a subject to circle more than one statement, but in that 
case, the scorer uses the one with the higher depression rating. The 
four items in each group are rated 0-3 and indicate increasing degrees 
of distress. For example, on the first of the 21 items, the subject is 
asked to decide among the following four choices: 
0 = do not feel sad. 
1 = I feel sad. 
2 = I am sad all the time and I can't snap out of it. 
3 = I am so sad or unhappy that I can't stand it. 
Beck et al. (1961) originally reported adequate test-retest and 
split-half reliability for the instrument, and these findings were 
confirmed for both a normal, nondepressed elderly sample and an elderly 
depressed s~mple using Research Diagnostic Criteria (RDC). 
In general, any self-report measure of depression may suffer from 
bias in that respondents are hesitant to acknowledge a "mental 
illness. " However, the BDI has been shown to be both reliable and 
valid. Test-retest reliability for psychiatric patients was .82 over a 
7-day period; the alpha coefficient of internal consistency for the 
same sample was .87. The correlation between scores on the test and 
ratings made by a psychiatrist was .69 for hospitalized psychiatric 
patients. The test also has been shown to discriminate significantly 
between patients diagnosed as depressive and patients diagnosed as 
having nonaffective disorders. 
Data Analysis Techniques 
Comparisons of HIV Seropositive to 
HIV Seronegative 
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Initially, independent group 1 tests were done between HIV 
seropositive and HIV seronegative subjects on each of the study 
variables. This included 20 subscales derived from the MBHI (all 
collected at baseline), and the Beck Depression Inventory (collected at 
baseline and 6-month intervals). This allowed a systematic comparison 
of psychological status, as measured by these particular instruments. 
Hypothesis Tests 
The wording of the hypothesis tests was modifie c (from the 
proposal) to incorporate mention of CD4 counts at each time period (6 
months, 12 months, 18 months, and 24 months) rather than only at 24 
months. The dependent variable for each hypothesis was the particular 
CD4 count at each data collection point after baseline. 
The independent variables were measures of Coping Style 
(Hypotheses 1-8), Psychogenic Attitudes (Hypotheses 9-14), 
Psychosomatic Correlates (Hypotheses 15-17), or Depression (Hypothesis 
18). In order to differentiate different levels on each independent 
variable, a transformed version of each independent variable was 
created based on a median split. Subjects scoring below or at the 
median were defined as being "low" on each scale, with subjects scoring 
above the median being classified as "high." 
For each hypothesis test, a set of analysis of covariance models 
was tested. This technique was selected in order to obtain a specific 
hypothesi s test for each hypothesis stated. For example, the first 
hypothesis stated that: 
Subjects who score higher on Introversive Coping at Baseline 
will not differ on CD4 counts at 6 months, 12 months, 18 
months, and 24 months from subjects with lower Introversive 
Coping scores at Baseline, while controlling for the effects 
of Baseline CD4 counts. 
This was tested with the four analyses of covariance models shown in 
Table 4. This analysis was then elaborated for each hypothesis 
Table 4 
Analysis of Covariance Framework for Hypothesis Tests 
Dependent Variable Predictors 
CD4 count (6 mo.) 1 ) Introversive Coping (High vs. Low) 
2) CD4 Baseline (covariate) 
CD4 count (12 mo.) 1 ) Introversive Coping (High vs. Low) 
2) CD4 Baseline (covariate) 
CD4 count (18 mo.) 1 ) Introversive Coping (High vs. Low) 
2) CD4 Baseline (covariate) 
CD4 count (24 mo.) 1 ) Introversive Coping (High vs. Low) 
2) CD4 Baseline (covariate) 
60 
utilizing a multivariate analysis of variance (MANOVA) model 
incorporating CD4 measures at 6 and 12 months as simultaneous dependent 
variables to be predicted. While it would have been desirable to 
incorporate all four data points (6, 12, 18, and 24 months) as 
dependent variables in the MANOVA analysis, this was not possible gi ven 
the attrition and loss of CD4 data at the later data poi nts. 
Elaboration Using Hierarchical 
Stepwise Multiple Regression 
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In addition to the specific hypothesis tests, exploratory multiple 
regression models were generated to explore the relative predictive 
effects of the independent variables on CD4 counts while controlling 
for baseline CD4 counts. The multivariate hypothesis was rephrased as: 
CD4 levels at each time period after baseline (6 months, 12 
months, 18 months, and 24 months) can be predicted by a 
multivariate combination of the coping styles, the psycho-
somatic correlates scales, the psychogenic attitudes scales, 
and level of Depression, while controlling for the effects of 
Baseline CD4 counts. 
This hypothesis was tested with a set of stepwise multiple regression 
models with Baseline CD4 counts being entered as a control variable in 
each model. 
In addition to the hypothesis tests, the relationship between 
background/demographic variables and all study variables was assessed. 
Assumptions and Limitations 
This study was necessarily limited by the relatively small sample 
size. Another limitation is that no single factor is truly the cause 
of an outcome, with some combination of interacting variables jointly 
yielding particular outcomes. This type of research design does not 
allow for random assignment to study groups. Another limitation to the 
study pertains to the validity of the instruments used. Self-report 
inventories are notoriously vulnerable to misrepresentation, and it is 
necessary to assume that subjects were sincere and honest in their 
responses to the battery of instruments. 
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The issue of attrition should also be addressed. There was 
considerably less data available for analysis at subsequent waves 
(i.e., waves of data collection after the Baseline). A certain amount 
of this attrition was attributable to mortality and physical 
incapacitation, with additional loss of data being due to difficulties 
in following up. The proportion of subjects using AZT was similar for 
each of the "wave" groups (the subjects for whom data were available at 
6-months, 12-months, 18-months, and 24-months). No statistically 
significant differences were found in the high or low groups for any 
MBHI scales or for the BDI. 
The attrition issue was particularly salient in the data analysis 
phase, in that the analysis required that data be available for both 
Baseline and the later data point (i.e., in the analysis of covariance 
framework). This led to smaller sample sizes than would have been 
optimal. 
Ethical Assurances 
This study is a component of a larger existing study, which has 
already undergone extensive Institutional Review (see Appendix for 
Consent Form). The larger study involved invasive procedures, and all 
ethical standards of the APA were followed. 
The participants were reassured that all data would be kept 
confidential. In order to insure confidentiality, each participant was 
assigned an anonymous identification number. All data forms were 
stored in a locked filing cabinet in the Neuropsychology Laboratory of 
the Brentwood Division of the West Los Angeles Veterans Affairs Medical 
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Center. Each form was identified only by an anonymous code number, and 
the codebook with identifying information was kept in a locked cabinet 
in the office of the Principal Investigator. 
The data utilized in the current study were strictly questionnaire 
data, and did not involve clinical or medical intervention. 
Participants were informed that they were participating in a research 
project as part of a doctoral dissertation, and had all aspects of 
their participation explained to them. They also had any questions 
answered. Each subject was also informed that he had the right to 
withdraw from the study at any time without prejudice, and that all 
data would be treated confidentially and used for research purposes 
only. Each subject was also told that results of the study would be 
made available to him if he expressed an interest. 
It was not anticipated that the content of the questionnaires 
would be upsetting to the subjects, and no adverse psychological 
reactions were observed. 
CHAPTER IV 
RESULTS 
Preliminary Analysis 
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Initial analysis was done comparing HIV seropositive subjects to 
th e HIV seronegative control group on the Baseline MBHI Coping Styles. 
Corroarisons were made for all subjects for whom baseline MBHI data were 
available. Differences between the two groups were evaluated using the 
incependent groups 1-test statistic. Results, shown in Table 5, 
incicated that the HIV seropositive subjects scored significantly lower 
on Social Coping (Q < .001) and Confident Coping (Q < .05), and 
si~ificantly higher on Inhibited Coping (Q < .01) and Sensitive Coping 
(Q < .01). 
Tatle 5 
CoTTJarison of HIV SeroQositive Subjects (N = 73) to HIV Seronegative 
Sutjects (N = 28) on MBHI CoQing Scales 
Group 
HIV+ HIV-
Coring Style Mean SD Mean SD t test 
I n1rovers i ve 41. 52 28.27 48.75 20.82 1. 51 
I nri b ited 61. 51 35.25 39.61 24.26 9.12** 
Cocpera ti ve 45.80 28.38 53.64 32.34 1.43 
Social 35.79 29.63 60.68 24.81 15.54*** 
Corf i dent 39. 90 28.22 53.50 23.93 5.09* 
Forceful 46.06 30.99 40.39 33.68 0.67 
Re~ectf u l 52.19 20.33 48.39 17.16 o. 77 
Sersitive 56.92 32.16 35.21 23.98 10.49** 
*Q <. 05; **_Q<.01; ***Q<.001 
Thus, there were differences on four of the eight MBHI Coping Style 
Scales, all in the expected direction. 
A similar analysis was done with the six Baseline Psychogenic 
Attitudes scales as outcomes. Results, shown in Table 6, indicated 
significant differences on all six variables. Analysis of the three 
Base.line Psychosomatic Correlates scales also showed significant 
Table 6 
Comparison of HIV Seropositive Subjects (N = 73) to HIV Seronegative 
Subjects (N=28) on MBHI Psychogenic Attitudes Scales 
Group 
HIV+ HIV-
Psychogenic 
Attitude Mean SD Mean SD 1 test 
Tension 49.62 30.94 37.03 24.62 3. 72* 
Stress 64. 56 26.57 39 .14 19.86 21.05*** 
Pessimism 59. 72 30.58 31.14 21.49 20.52*** 
Despair 63.62 35.84 40.39 33.35 8.82** 
Alienation 56.29 34.53 37.64 25.18 2.99** 
Anxiety 62.25 23.82 34.86 19.88 29.18*** 
*_Q_<.05; **_Q_<.01; ***_Q_<.001 
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differences on all three scales; in all three cases, HIV seropositive 
subjects scored significantly higher on the psychosomatic correlates 
scales (Table 7). A final comparison between the two groups was done 
with the Beck Depression Inventory at Baseline and 12-month time frames 
as dependent variable. Results, shown in Table 8, revealed that HIV 
seropositive subjects were significantly more depressed at both 
Baseline (Q < .001) and 12 months (Q < .01). 
Table 7 
Comparison of HIV Seropositive Subjects (N = 73) to HIV Seroneqative 
Subjects (N=28) on MBHI Psychosomatic Correlates Scales 
Group 
HIV+ HIV-
Psychosomatic 
Correlates Mean SD Mean SD t-test 
Allergic 
Inclination 70. 71 24.22 44.79 20.49 25.15*** 
Gastrointestinal 71. 34 18.88 40.50 13.36 62.54*** 
Cardiovascular 68.51 24.47 50.75 17.55 12.28*** 
***Q<.001 
Table 8 
Comparison of HIV Seropositive Subjects (N = 73) to HIV Seroneqative 
Subjects (N = 28) on Beck Depression Scores, Baseline, and 12-Month 
Time Periods 
Group 
HIV+ HIV-
Mean SD Mean SD t-test 
[epression, 
Easeline 13.39 8.52 3.67 4.09 32.46*** 
[epression, 
12 Months 7.25 10.39 1. 97 2.87 7.27** 
'*Q < .01; *** Q <.001 
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Hypothesis Tests 
The first set of eight hypotheses utilizes the eight coping style 
scales of the MBHI as independent variables. 
Hypothesis #1 
Subjects who score higher on Introversive Coping at Baseline will 
not differ on CD4 counts at 6 months, 12 months, 18 months, and 24 
months from subjects with lower Introversive Coping scores at Baseline, 
while controlling for the effects of Baseline CD4 counts. 
This hypothesis was tested using a set of four analysis of 
covariance models. Each model had one of the four CD4 counts as 
dependent variable (6, 12, 18, and 24 months), with CD4 counts at 
Baseline being used as a covariate. The independent variable is a 
dichotomous variable reflecting low ver sus high levels of Introversive 
Coping, defined by the median split. This method was then replicated 
for the other hypothesis tests, with the independent variable in each 
case being a 2-level nominal level variable reflecting low versus high 
levels of that particular coping style. 
Results of the first hypothesis test are shown in Table 9. As can 
be seen, there are no significant differences on CD4 counts at any of 
the time periods, while controlling for Baseline CD4 levels. Thus, the 
null hypothesis is supported, and there is no evidence of a 
relationship between Introversive Coping and immune system functioning. 
68 
Table 9 
Effects of Introversive Coping Style on CD4 Counts at Each Time Period, 
While Controlling for Baseline CD4 Counts 
Introversive Coping 
Low High 
N Mean SD Mean so F Test 
CD4 Count, 6 Months 57 381. 7 249.3 327.5 208.6 0.38 
CD4 Count, 12 Months 45 293.1 184.9 305.3 218.2 0.43 
CD4 Count, 18 Months 26 297.8 189.9 198.4 198.5 0.80 
CD4 Count, 24 Months 24 236.6 178.9 252.6 247.5 0.46 
Note: Each ANC0VA model controls CD4 at Baseline as a covariate in the 
model; Table shows F test for the effect of Coping style with covariate 
in the model. -
Hypothesis #2 
Subjects who score higher on Inhibited Coping at Baseline will not 
differ on CD4 counts at 6 months, 12 months, 18 months, and 24 months 
from subjects with lower Inhibited Coping scores at baseline, while 
controlling for the effects of Baseline CD4 counts. 
Results of the second hypothesis test, shown in Table 10, also 
show no significant differences between those who exhibit low levels of 
Inhibited Coping as compared to those with high levels of Inhibited 
Coping. Thus, the second null hypothesis is supported, and there is no 
evidence of a relationship between Inhibited Coping and immune system 
functioning. 
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Table 10 
Effects of Inhibited Coping Style on CD4 Counts at Each Time Period, 
While Controlling for Baseline CD4 Counts 
Inhibited Coping 
Low High 
N Mean SD Mean SD F Test 
CD4 Count, 6 Months 57 283.3 144.19 407.1 265.5 2.33 
CD4 Count, 12 Months 45 263.3 196.8 327.9 203.7 0.01 
CD4 Count, 18 Months 26 218.2 177. 6 292.8 205.9 0.01 
CD4 Count, 24 Months 24 207 .0 200.8 266.9 179.5 0.04 
Note: Each ANC0VA model controls CD4 at Baseline as a covariate in the 
model; Table shows F test for the effect of Coping style with covariate 
in the model. 
Hypothesis #3 
Subjects who score higher on Cooperative Coping at Baseline will 
not differ on CD4 counts at 6 months, 12 months, 18 months, and 24 
months from subjects with lower Cooperative Coping scores at Baseline, 
while controlling for the effects of Baseline CD4 counts. 
Results of the third hypothesis test, shown in Table 11, are 
similar, with no significant differences being found between those who 
exhibit low levels of Cooperative Coping as compared to those with high 
levels of Cooperative Coping. Thus, the third null hypothesis is 
supported, and there is no evidence of a relationship between 
Cooperative Coping and immune system functioning. 
70 
Table 11 
Effects of Cooperative Coping Style on CD4 Counts at Each Time Period, 
While Controlling for Baseline CD4 Counts 
Cooperative Coping 
Low High 
N Mean SD Mean SD F Test 
CD4 Count, 6 Months 57 344.7 238.9 373.8 226.3 0.87 
CD4 Count, 12 Months 45 291.5 166.5 307.5 237.4 0.17 
CD4 Count, 18 Months 26 300.2 148.4 193.9 257.7 2.60 
CD4 Count, 24 Months 24 255.5 118. 2 223.5 290.0 0.34 
Note: Each ANCOVA model controls CD4 at Baseline as a covariate in the 
model; Table shows [ test for the effect of Coping style with covariate 
in the model. 
Hypothesis #4 
Subjects who score higher on Sociable Coping at Baseline will not 
differ on CD4 counts at 6 months, 12 months, 18 months, and 24 months 
from subjects with lower Sociable Coping scores at Baseline, while 
controlling for the effects of Baseline CD4 counts. 
Results of the fourth hypothesis test, shown in Table 12, show 
statistically significant differences between those who exhibit low 
levels of Sociable Coping as compared to those with high levels of 
Sociable Coping at 18 months. There is a tendency for subjects with 
higher levels of sociable coping to have somewhat lower CD4 cell counts 
at 6 months, as well, but this difference was not significant. Thus, 
the fourth null hypothesis is not supported, and there is evidence of a 
relationship between Sociable Coping and immune system functioning. 
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Table 12 
Effects of Sociable Coping Style on CD4 Counts at Each Time Period, 
While Controlling for Baseline CD4 Counts 
Sociable Coping 
Low High 
N Mean SD Mean SD I Test 
CD4 Count, 6 Months 57 422.6 264.4 268.6 138.2 3.27 
CD4 Count, 12 Months 45 341. 0 197.3 253.2 191. 7 0.01 
CD4 Count, 18 Months 26 349.9 191. 7 156.8 142.2 4.41* 
CD4 Count, 24 Months 24 269.8 170.8 209.5 236.9 0.04 
Note: Each ANCOVA model controls CD4 at Baseline as a covariate in the 
model; Table shows f. test for the effect of Coping style with covariate 
in the model. 
*.Q_<.05 
Hypothesis #5 
Subjects who score higher on Confident Coping at Baseline will 
not differ on CD4 counts at 6 months, 12 months, 18 months, and 24 
months from subjects with lower Confident Coping scores at Baseline, 
while controlling for the effects of Baseline CD4 counts. 
Results of the fifth hypothesis test, shown in Table 13, revealed 
no significant differences between those who exhibit low levels of 
Confident Coping as compared to those with high levels of Confident 
Coping. Thus, the fifth null hypothesis is supported, and there is no 
evidence of a relationship between Confident Coping and immune system 
functioning. 
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Table 13 
Effects of Confident Coping Style on CD4 Counts at Each Time Period, 
While Controlling for Baseline CD4 Counts 
Confident Coping 
Low High 
N Mean SD Mean SD F test 
CD4 Count, 6 Months 57 379.1 257.1 335.2 204.2 0 .12 
CD4 Count, 12 Months 45 314.6 182.1 287.6 209.8 0.41 
CD4 Count, 18 Months 26 290.4 234.2 235.6 151.0 0.01 
CD4 Count, 24 Months 24 247.0 210.9 239.2 202.1 0.16 
Note: Each ANC0VA model controls CD4 at Baseline as a covariate in the 
model; Table shows F test for the effect of Coping style with covariate 
in the model. -
Hypothesis #6 
Subjects who score higher on Forceful Coping at Baseline will not 
differ on CD4 counts at 6 months, 12 months, 18 months, and 24 months 
from subjects with lower Forceful Coping scores at Baseline, while 
controlling for the effects of Baseline CD4 counts. 
Results of the sixth hypothesis test, shown in Table 14, showed 
no significant differences between those classified as having low 
levels of Forceful Coping as compared to those with high levels of 
Forceful Coping. Thus, the sixth null hypothesis is supported, and 
t here is no evidence of a relationship between Forceful Coping and 
immune system functioning. 
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Table 14 
Effects of Forceful Coping Style on CD4 Counts at Each Time Period, 
While Controlling for Baseline CD4 Counts 
Forceful Coping 
Low High 
N Mean SD Mean SD F Test 
CD4 Count, 6 Months 57 338.2 232.7 376.2 233.4 0.22 
CD4 Count, 12 Months 45 300.5 232.1 296.8 172 .1 1.20 
CD4 Count, 18 Months 26 201.0 237.3 304.3 156.3 1. 36 
CD4 Count, 24 Months 24 237.3 276.8 245.9 139.4 0.01 
Note: Each ANCOVA model controls CD4 at Baseline as a covariate in the 
model; Table shows I test for the effect of Coping style with covariate 
in the model. 
Hypothesis #7 
Subjects who score higher on Respectful Coping at Baseline will 
not differ on CD4 counts at 6 months, 12 months, 18 months, and 24 
months from subjects with lower Respectful Coping scores at Baseline, 
while controlling for the effects of Baseline CD4 counts. 
Results of the seventh hypothesis test are shown in Table 15. 
Results show no significant differences between those subjects with low 
levels of Respectful Coping as compared to those with high levels of 
Respectful Coping. Thus, the seventh null hypothesis is supported, and 
there is no evidence of a relationship between Respectful Coping and 
immune system functioning. 
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Table 15 
Effects of Respectful Coping Style on CD4 Counts at Each Time Period, 
Wh i 1 e Controlling for Baseline CD4 Counts 
Respectful Coping 
Low High 
N Mean SD Mean SD F Test 
CD4 Count, 6 Months 57 390.3 254.7 335.8 216.3 0.01 
CD4 Count, 12 Months 45 340.3 204.1 276.5 193.9 0.51 
CD4 Count, 18 Months 26 289.8 185.5 245.2 205.4 0. 72 
CD4 Count, 24 Months 24 318.5 237.6 198.9 170.6 1. 43 
Note: Each ANC0VA model controls CD4 at Baseline as a covariate in the 
model; Table shows [ test for the effect of Coping style with covariate 
in the model. 
Hypothesis #8 
Subjects who score higher on Sensitive Coping at Baseline will 
not differ on CD4 counts at 6 months, 12 months, 18 months, and 24 
months from subjects with lower Sensitive Coping scores at Baseline, 
while controlling for the effects of Baseline CD4 counts. 
Results of the eighth hypothesis test, shown in Table 16, are 
similar. There are no significant differences between those who 
exhibit low levels of Sensitive Coping compared to those with high 
levels of Sensitive Coping. There was a tendency for subjects who 
scored lower on sensitive coping to have somwhat lower CD4 counts at 6 
months, but this difference was not quite significant. Thus, the 
eighth null hypothesis is supported, and there is no evidence of a 
relationship between Sensitive Coping and immune system functioning. 
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Table 16 
Effects of Sensitive Coping Style on CD4 Counts at Each Time Period, 
Wh i 1 e Controlling for Baseline CD4 Counts 
Respectful Coping 
Low High 
N Mean SD Mean SD F Test 
CD4 Count, 6 Months 57 290.5 136.8 394.6 264.5 2. 72 
CD4 Count, 12 Months 45 281. 3 178.2 309.8 211. 9 0.01 
CD4 Count, 18 Months 26 200.7 169.8 314.0 204.9 0.48 
CD4 Count, 24 Months 24 235.0 225.9 247.5 190.9 0.23 
Note: Each ANC0VA model controls CD4 at Baseline as a covariate in the 
model; Table shows I test for the effect of Coping style with covariate 
i n t he mode 1 • 
Results of the first eight hypotheses, each of which postulated 
one of the MBHI Coping Styles as dependent variables, showed no 
significant findings, except for Sociable Coping at 18 months. Thus, 
it appears that there is little or no relationship between Millon 1 s 
coping styles and immune system functioning in an HIV-infected sample. 
The next set of hypotheses was tested in similar fashion. Each 
hypothesis states a null relationship between one of the MBHI 
psychogenic attitudes scales and immune system functioning, as 
operationalized by CD4 cell counts. 
Hypothesis #9 
Subjects who score higher on Chronic Tens ion at Baseline will not 
differ on CD4 counts at 6 months, 12 months, 18 months, and 24 months 
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from subjects with lower Chronic Tension scores at Baseline, while 
contr~lling for the effects of Baseline CD4 counts. 
As shown in Table 17, there was a significant effect of Chronic 
Tension on CD4 counts at both 6 months and 18 months. In both cases, 
those with higher levels of chronic tension had lower CD4 counts (Q < 
.01 for both 6 and 18 months). Thus, the null hypothesis can be 
rejected. There is a degree of support for t he directional hypothesis, 
with igher levels of chronic tension being associated with impaired 
immune system functioning. 
Table 17 
Effects of Chronic Tension on CD4 Counts at Each Time Period, While 
Contro 11 i ng for Baseline CD4 Counts 
Chronic Tension 
Low High 
N Mean SD Mean SD F Test 
CD4 Count, 6 Months 57 421. 9 254.2 227.3 172 .1 7.88** 
CD4 Count, 12 Months 45 324.8 190.8 266.9 205.4 1. 60 
CD4 Count, 18 Months 26 356.9 131. 3 169.1 206.2 7.51** 
CD4 Count, 24 Months 24 354.2 149.2 230.6 249.1 0.14 
Note: Each ANCOVA model controls CD4 at Baseline as a covariate in the 
model; Table shows F test for the effect of Coping style with covariate 
in the model. 
**Q < .01 
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HyJothesis #10 
Subjects who score higher on Recent Stress at Baseline will not 
differ on CD4 counts at 6 months, 12 months, 18 months, and 24 months 
fr:im subjects with lower Recent Stress scores at Baseline, while 
c01trolling for the effects of Baseline CD4 counts. 
Results of the tenth hypothesis test, shown in Table 18, reveal 
trat there is no significant difference between those subjects with low 
levels of Recent Stress and those with high levels of Recent Stress. 
Th.is, the tenth null hypothesis is supported, and there is no evidence 
of a relationship between Recent Stress and immune system functioning. 
Tcble 18 
Effects of Recent Stress on CD4 Counts at Each Time Period, While 
Centro 11 i ng for Baseline CD4 Counts 
Recent Tension 
Low High 
N Mean SD Mean SD E Test 
C[4 Count, 6 Months 57 390.0 280.9 313.4 131. 9 0.99 
CC4 Count, 12 Months 45 313.3 210.9 278.5 181.5 0.01 
C[4 Count, 18 Months 26 265.6 187.4 214.6 222.5 0.02 
C[4 Count, 24 Months 24 314.0 204.9 200.7 169.8 0.48 
Ncte: Each ANC0VA model controls CD4 at Baseline as a covariate in the 
mcdel; Table shows F test for the effect of Coping style with covariate 
i r the model . 
H pot hes is #11 
Subjects who score higher on Premorbid Pessimism at Baseline will 
net differ on CD4 counts at 6 months, 12 months, 18 months, and 24 
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morths from subjects with lower Premorbid Pessimism scores at Baseline, 
wh'le controlling for the effects of Baseline CD4 counts. 
As shown in Table 19, there is a significant effect of Premorbid 
Pe~simism on CD4 counts at 6 months. Individuals with higher levels of 
PrEmorbid Pessimism had lower CD4 counts at 6 months (Q < .05). Thus, 
thE null hypothesis of no relationship can be rejected. The 
directional hypothesis is supported, with results showing an effect of 
Ba~l ine Pessimism on CD4 counts 6 months later. 
Tatle 19 
Efiects of Premorbid Pessimism on CD4 Counts at Each Time Period, While 
Cortrollinq for Baseline CD4 Counts 
Premorbid Pessimism 
Low High 
N Mean SD Mean SD F Test 
CDL Count, ·5 Months 57 405.9 273.0 291. 5 138.2 5.29* 
CDL Count, 12 Months 45 338.4 213.3 260.6 177 .6 1. 53 
CDL Count, 18 Months 26 303.1 214.1 214.0 164.5 1. 27 
CDL Count, 24 Months 24 266.1 180.7 208.2 233.6 0.46 
Noie: Each ANCOVA model controls CD4 at Baseline as a covariate in the 
mocel; Table shows F test for the effect of Coping style with covariate 
in the model . 
*Q<. 05 
Hy1othes is #12 
Subjects who score higher on Future Despair at Baseline will not 
di fer on CD4 counts at 6 months, 12 months, 18 months, and 24 months 
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from subjects with lower Future Despair scores at baseline, while 
controlling for the effects of Baseline CD4 counts. 
As shown in Table 20, there is a significant effect of Future 
Despair on CD4 counts at 6 months. Individuals with higher levels of 
future despair had lower 14 counts at 6 months (Q < .05). Thus, the 
null hypothesis of no relationship between Future Despair and immune 
system functioning can be rejected. The directional hypothesis is 
supported for the effect of Future Despair on CD4 counts 6 months 
later. 
Table 20 
Effects of Future Despair on CD4 Counts at Each Time Period, While 
Controlling for Baseline CD4 Counts 
CD4 Count, 6 Months 
CD4 Count, 12 Months 
CD4 Count, 18 Months 
CD4 Count, 24 Months 
N 
57 
45 
26 
24 
Low 
Mean 
399.6 
324.6 
307.2 
264.6 
Future Despair 
SD 
240.5 
171. 2 
203.8 
172.6 
High 
Mean 
300.2 
270.6 
181.0 
203.5 
SD F Test 
210.4 3.87* 
222. 7 1.09 
154.4 0.92 
250.6 0.12 
Note: Each ANC0VA model controls CD4 at Baseline as a covariate in the 
model; Table shows f. test for the effect of Coping style with covariate 
in the model. 
*Q<.05 
Hypothesis #13 
Subjects who score higher on Social Alienation at Baseline will 
not differ on CD4 counts at 6 months, 12 months, 18 months, and 24 
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months from subjects with lower Social Alienation scores at Baseline, 
while controlling for the effects of Baseline CD4 counts. 
Results of this hypothesis test, shown in Table 21, show that 
there were no significant differences between subjects with low 
A ienation as compared to those with high levels of Alienation. There 
was a tendency for those with high levels of Social Alienation to have 
somewhat lower CD4 counts at 6 months; however, this is not a 
significant finding. Thus, the null hypothesis is supported, and there 
is no evidence of a relationship between Social Alienation 
and immune system functioning. 
Table 21 
Effects of Social Alienation on CD4 Counts at Each Time Period, While 
Controlling for Baseline CD4 Counts 
Social Alienation 
Low High 
N Mean SD Mean SD [ Test 
CD4 Count, 6 Months 57 398.3 264.6 290.5 145.3 2.02 
CD4 Count, 12 Months 45 327.9 203.7 263.3 188.7 0.01 
CD4 Count, 18 Months 26 274.5 207.9 241.6 178 .1 0.04 
CD4 Count, 24 Months 24 249.7 184.1 229.6 240.1 0.01 
Note: Each ANCOVA model controls CD4 at Baseline as a covariate in the 
model; Table shows F test for the effect of Coping style with covariate 
in the model. -
Hypothesis #14 
Subjects who score higher on Somatic Anxiety at Baseline will not 
differ on CD4 counts at 6 months, 12 months, 18 months, and 24 months 
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fr om subjects with lower Somatic Anxiety scores at Baseline, while 
controlling for the effects of Baseline CD4 counts. 
As shown in Table 22, there is a significant effect of Somatic 
Anxiety on CD4 counts at 6 months. Individuals with higher Somatic 
Anxie ty had lower CD4 counts at 6 months (Q < .01). There is a 
tendency at the 18 month time period, with the effect holding up in the 
predicted direction (but not quite significant). Thus, the null 
hyoothesis can be rejected, and there i s an effect of Somatic Anxiety 
on CD4 counts 6 months later. 
Tao le 22 
Effe cts of Somatic Anxiety on CD4 Counts at Each Time 
Per iod, While Controlling for Baseline CD4 Counts 
CD4 Count, 6 Months 
CD4 Count, 12 Months 
CD4 Count, 18 Months 
CD4 Count, 24 Months 
N 
57 
45 
26 
24 
Low 
Mean 
407.7 
317.8 
329.7 
284.7 
Somatic Anxiety 
SD 
259.6 
219.6 
213.9 
184.9 
High 
Mean 
275.2 
272.5 
162.9 
200.1 
SD F Test 
112.4 6.86** 
165.5 0.24 
104.8 2.86 
215.6 0.32 
Note: Each ANC0VA model controls CD4 at Base line as a covariate in the 
model; Table shows F test for the effect of Coping style with covariate 
i n the mode l . -
**p<.01. 
Hypothesis #15 
Subjects who score higher on Allergic Inclination at Baseline will 
not differ on CD4 counts at 6 months, 12 months, 18 months, and 24 
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months from subjects with lower Allergic Inclination scores at 
Baseline, while controlling for the effects of Baseline CD4 counts. 
As can be seen in Table 23, there is a significant effect of 
Allergic Inclination on CD4 counts at 6 months. Individuals with 
higher levels of Allergic Inclination had lower CD4 counts at 6 months 
(Q < .05). Thus, the null hypothesis can be rejected, with the 
findings showing a significant effect of Allergic Inclination on CD4 
counts 6 months later. 
Table 23 
Effects of Allergic Inclination on CD4 Counts at Each Time 
Period, While Controlling for Baseline CD4 Counts 
Allergic Inclination 
Low High 
N Mean SD Mean SD 
CD4 Count, 6 Months 57 389.9 273.6 299.2 106.7 
CD4 Count, 12 Months 45 313.8 215.8 277. 9 173.5 
CD4 Count, 18 Months 26 322.2 207.3 174.3 139.7 
CD4 Count, 24 Months 24 262.8 180.3 213.0 235.3 
F Test 
5.62* 
0.34 
1. 77 
0.66 
Note: Each ANCOVA model controls CD4 at Baseline as a covariate in the 
model; Table shows [ test for the effect of Coping style with covariate 
in the mode 1. 
*Q<. 05 
Hypothesis #16 
Subjects who score higher on Gastro i ntestinal Susceptibility at 
Baseline will not differ on CD4 counts at 6 months, 12 months, 18 
months, and 24 months from subjects with lower Gastrointestinal 
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Su5ceptibility scores at Baseline, while controlling for the effects of 
Ba5eline CD4 counts. 
Table 24 shows that there is a significant effect of 
Ga~trointestinal Susceptibility on CD4 counts at both 6 months and 18 
morths (both significant at Q < .01). 
Tacle 24 
Effects of Gastrointesntinal Susceptibility on CD4 Counts at Each Time 
Period, While Controlling for Baseline CD4 Counts 
Gastrointestinal Susceptibility 
Low High 
N Mean SD Mean SD F Test 
CD4 Count, 6 Months 57 398.7 258.6 266.7 116.5 7.03** 
C04 Count, 12 Months 45 331. 4 206.4 248.8 177 .1 2.79 
CD4 Count, 18 Months 26 324.9 197.3 118. 5 76.0 7.21** 
CD4 Count, 24 Months 24 280.0 169.6 188.1 238.8 0.95 
Note: Each ANCOVA model controls CD4 at Baseline as a covariate in the 
model; Table shows [ test for the effect of Coping style with covari at e 
in the model. 
**Q<.Ol 
In both cases, those with higher levels of Gastrointestinal 
Susceptibility had lower CD4 counts. Additionally, there is a nearly 
s ·gnificant difference at the 12-month time period. Thus, the null 
hypothesis can be rejected. There is support for the effect of 
A' lergic Inclination on CD4 counts 6 and 18 months later. 
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Hypothesis #17 
Subjects who score higher on Cardiovascular Tendency at Baseline 
will not differ on CD4 counts at 6 months, 12 months, 18 months, and 24 
months from subjects with lower Cardiovascular Tendency scores at 
Baseline, while controlling for the effects of Baseline CD4 counts. 
Table 25 shows that there is a significant effect of 
Cardiovascular Tendency on CD4 counts at both 6 months (Q< .01) and 18 
months (Q < .05). In both cases, thos e with higher levels of 
Cardiovascular Tendency had lower CD4 counts. This implies that the 
null hypothesis can be rejected. These results provide statistical 
support for the effect of Cardiovascular Tendency on CD4 counts at 6 
and 18 months. 
Table 25 
Effects of Cardiovascular Tendency on CD4 Counts at Each Time Period, 
While Controlling for Baseline CD4 Counts 
Cardiovascular Tendency 
Low High 
N Mean SD Mean SD F Test 
CD4 Count, 6 Months 57 403.6 276.4 294.7 131. 7 6.44** 
CD4 Count, 12 Months 45 309.9 221. 0 284.7 169.8 0.26 
CD4 Count, 18 Months 26 348.5 195.1 158.4 138.9 5.24* 
CD4 Count, 24 Months 24 283.9 170.6 192.6 231.1 1.49 
Note: Each ANCOVA model controls CD4 at Baseline as a covariate in the 
model; Table shows I test for the effect of Coping style with covariate 
in the model . 
*Q<.05; **Q<.0l 
~ypothesis #18 
Subjects who score higher on Depression at Baseline will not 
ciffer on CD4 counts at 6 months, 12 months, 18 months, and 24 months 
:rom subjects with lower Depression scores at Baseline, while 
controlling for the effects of Baseline CD4 counts. 
Results of this hypothesis test, shown in Table 26, show that 
:here are no significant differences between those who exhibit low 
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evels of Depression compared to those with high levels of Depression. 
-here was a tendency for subjects who scored lower on Depression to 
lave somewhat higher CD4 counts at 6 months, but this difference was 
tot quite significant. Thus, the null hypothesis is supported, and 
:here is no evidence of a relationship between Baseline Depression and 
mmune system functioning. 
lypothesis #19 
CD4 levels at each time period after baseline (6 months, 12 
nonths, 18 months, and 24 months) cannot be predicted by a multivariate 
combination of the coping styles, the psychosomatic correlate scales, 
:he psychogenic attitudes scales, and level of Depression, while 
controlling for the effects of Baseline CD4 counts. 
This multivariate hypothesis was tested by specifying a 
:tepwise multiple regression . The initial regression analysis, shown 
n Table 27, has CD4 counts at 6 months as the dependent variable. In 
:he first step, Baseline CD4 count is forced into the regression model 
(5 an independent variable. As expected, it is highly significant and 
ccounts for 54.3% of the variance in 6 month CD4 counts. 
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Table 26 
Effects of Depression (Baseline) on CD4 Counts at Each Time Period, 
While Controlling for Baseline CD4 Counts 
Depression 
Low High 
ANCOVA N Mean SD Mean SD F Test 
CD4 Count, 6 Months 57 408.4 262.1 278.2 142.5 3.06 
CD4 Count, 12 Months 45 315.2 201. 4 273.0 170.9 0.05 
CD4 Count, 18 Months 26 244.3 210. 9 199.7 170.8 0.03 
CD4 Count, 24 Months 24 246.4 192.3 214.6 222.5 0.01 
Note: Each ANCOVA model controls CD4 at Baseline as a covariate in the 
model; Table shows F test for the effect of Coping style with covariate 
in the model. -
Table 27 
Exploratory Multiple Regression Analysis: Model #1 Dependent Variable: 
CD4 Counts, 6 Months 
Independent Variable 
CD4 Count, Baseline 
Cardiovascular 
F statistic 
Adjusted r-square (variance explained) 
Note: Cells show standardized beta coefficients. 
***.Q_<.001 
Step 
1 
0.74*** 
50.87*** 
54.3% 
of the Model 
2 
0. 72*** 
0.35*** 
41.52*** 
65.9% 
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In the second step of the analysis, the entire set of independent 
variables was offered for consideration in a stepwise regression 
framework (see Table 27). The only independent variable selected as 
s ignificant was Cardiovascular Tendency, which explained an additional 
11.6% of the variance in the dependent variable. 
The second stepwise regressi on model, shown in Table 28, 
replicated this procedure with CD4 count s at 12 months as the dependent 
variable. Baseline CD4 counts, again forced in the first step of the 
model, accounted for 64.1% of the variance in 12-month CD4 counts. In 
this stepwise model, both Cooperative and Introversive Coping styles 
were selected in subsequent steps. 
Table 28 
Exploratory Multiple Regression Analysi s : Model #2 Dependent Variable: 
CD4 Counts, 12 Months 
Independent Variable 
CD4 Count, Baseline 
Cooperative Coping 
Introversive Coping 
F-statistic 
Adjusted r-square (variance explained) 
Step of the Model 
1 2 3 
0.77*** 0.83*** 0.92*** 
0.24* 0.36** 
0.26* 
77.79*** 34.32*** 29.18*** 
64.1% 66.9% 71.9% 
Note: Cells show standardized beta coefficients. 
*Q<.05; **_p_<.01; ***_p_<.001 
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Although both of these coping styles are significant (Cooperative 
at Q < .01 and Introversive at Q < .05), the combination of the two 
increases the variance explained only slightly. 
In addition, the hypothesis tests were elaborated by calculating 
a repeated measures MAN0VA for each hypothesis. Each such analysis 
incorporated CD4 measures as joint dependent variables and the specific 
scale for each hypothesis as independent variables (predictors). These 
MAN0VA models, shown in Table 29, incorporated three simultaneous 
dependent variables: CD4 counts at baseline, 6 months, and 12 months. 
It was impractical to include CD4 counts at 18 and 24 months as 
dependent variables due to attrition in the sample (i.e., due to 
inadequate cases with full CD4 data). A separate MAN0VA model was run 
for each hypothesis test. In each case the three dependent variables 
where CD4 counts at baseline, 6 months, and 12 months. The independent 
variable was the MBHI measure specified in Hypotheses 1 through 17, or 
the Beck Depression Scale for Hypothesis 18. 
The lack of significance in the MAN0VA models is surprising, 
especially given the significant findings in the original hypothesis 
tests for the psychogenic attitudes and psychosomatic correlates 
scales. However, this can probably be attributed to the drop in the 
number of valid cases, and to statistical artifacts resulting from 
insufficient degrees of freedom in the MAN0VA models. 
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Table 29 
Multivariate Analysis of Variance With CD4 at Baseline, 6 Months, and 
12 Months as DeQendent Variables 
H# Variable F test Q value 
1 Introversive 0. 96 0.39 
2 Inhibited 1.02 0.36 
3 Cooperative 1.40 0.26 
4 Social 1.14 0.33 
5 Confident 1.41 0.25 
6 Forceful 1. 26 0.29 
7 Respectful 0.53 0.59 
8 Sensitive 0.83 0.44 
9 Tension 1. 21 0.30 
10 Stress 1.00 0.38 
11 Pessimism 1.12 0.33 
12 Despair 1.13 0.33 
13 Alienation 1.05 0.36 
14 Anxiety 1.14 0.33 
15 Allergic Inclination 1.07 0.35 
16 Gastrointestinal 1. 32 0.27 
17 Cardiovascular 1.14 0.33 
18 Depression 1.18 0.31 
CHAPTER V
DISCUSSION 
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The current study addressed the issue of the relationship between 
psychological well-being and immune function in a sample of HIV 
seropositive males drawn from the patient population at the Veteran's 
Affairs Medical Center in West Los ngeles. This chapter will (a) 
summarize the methods of the study and the results reported in Chapter 
IV, (b) discuss those findings in light of the literature review, (c) 
draw relevant conclusions from the findings, and (d) discuss some 
fruitful directions for future research. 
Summary 
Summary of Methods 
The current study employed a longitudinal, quasi-experimental 
design to assess the relationship between various psychological 
independent variables and immune system functioning, operationalized as 
CD4 counts, in a cohort of AIDS patients over a 24-month time period. 
The study involved the collection of a battery of psychological and 
neuropsychological instruments and CD4 data at Baseline, as well as 
data on depression at Baseline and 12-months and CD4 counts at 6-month 
intervals over a 2-year period. The study analyzed the effect of 
coping style, stress, and somatic symptoms (the MBHI measures), as well 
as the effects of Baseline depression, on immune system functioning 
over the 2-year period. 
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Summary of Preliminary Analysis 
Results of the preliminary analyses comparing HIV seropositive to 
HIV seronegative subjects were generally consistent with what might be 
expected given what we know about the effects of the HIV diagnosis. 
There were differences on four of the eight MBHI coping style 
scales. HIV seropositive subjects scored significantly higher on the 
inhibited and sensitive coping scales. Similarly, they scored lower on 
confident and social coping scales. There were consistent significant 
differences between the two groups on all of the psychogenic attitudes, 
with the HIV seropositive subjects experiencing a great deal more 
stress, as measured by these variables. 
Summary of Hypothesis Tests 
There was only one observed effect of the MBHI Coping Styles 
(Sociable at 18 months). No other effects were observed on immune 
system functioning. Based on the findings of the first set of eight 
hypotheses with the Coping Styles as dependent variables, it appears 
that there is little or no relationship between Millon 1 s coping styles 
and immune system functioning, at least in this sample of HIV-positive 
subjects. 
The second set of hypotheses (Hypotheses 9 through 14) dealt with 
the six psychogenic attitudes as dependent variables. Results were 
somewhat more encouraging with this block of MBHI variables, with 
significance being found on four of the six psychogenic attitudes. 
Specifically, results of these hypotheses tests are summarized in Table 
30. 
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Table 30 
Summa'y of Hypothesis Tests With Psychogenic Attitudes as 
Predi:tors of CD4 Counts 
Psych)genic Attitude 
Chronic Tension 
Recen Stress 
Premo'bid Pessimism 
Futur~ Despair 
Social Alienation 
Somatic Anxiety 
Result 
Significant at 6 and 18 Months 
Not Significant 
Significant at 6 Months 
Significant at 6 Months 
Not Significant 
Significant at 6 Months 
There were also significant effects of the Psychosomatic 
Correlates scales on immune functioning, with significant findings on 
Aller Jic Inclination, Gastrointestinal Susceptibility, and 
CardiJvascular Tendency. However, there was no effect of level of 
depression on immune system functioning. 
Discussion of Findings 
Chronic stress and anxiety are normal correlates of the HIV-
positive diagnosis, with various researchers reporting that over half 
of HIV-positive gay males experience elevated rates of anxiety and 
insonnia. While a certain amount of anxiety may be useful, in that it 
encourages adaptive behaviors and compliance to medical regimens, 
excessive anxiety can be quite harmful in several areas. For example, 
excessive anxiety is likely to contribute to a sense of helplessness 
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and to a perceived inability to do anything about the situation 
(Seligman's learned helplessness). One possible negative outcome is 
t1at the chronically stressed individual may continue to engage in 
m3ladaptive behaviors due to the totally external locus of control 
o ientation. 
High levels of Chronic Tension, as measured by the MBHI, are 
likely to be related to various psychosomatic and physical ailments 
(Millon et al., 1982). Individuals who have higher levels of chronic 
tension typically maintain a rapid pace and live under a great deal of 
self-imposed pressure. It is quite possible that such a lifestyle 
could contribute to an impaired immune system function in a person with 
AIDS, especially if the rapid pace is maintained over a long period of 
time. 
In addition, higher levels of premorbid pessimism were associated 
with impaired immune system functioning (at 6 months). This may be 
related to the fact that some individuals tend to adopt a dispositional 
attitude characterized by feelings of helplessness. The effects on the 
immune system could be felt either directly or indirectly (i.e., 
through a mediating variable such as lower levels of compliance due to 
feelings of helplessness). 
Also found to be significantly related to immune system variables 
was the level of Future Despair, which reflects the individual's 
willingness to plan for and look forward to the future. Individuals 
scoring higher on the despair scale are likely to perceive their 
medical condition in more negative terms, which could lead them to an 
more generally pessimistic outlook on the remainder of their lives. 
Finally, there was also an effect of Somatic Anxiety, which measures 
the preoccupation and fears individuals have about their bodies. 
Higher scorers tend to be hypochondriacal, and may overreact to the 
discomforts of particular treatments. 
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At least two of the four psychogenic attitudes found to be 
significantly related to immune system functioning--tension and anxiety 
--are also part of an ongoing syndrome of stress. Researchers have 
recognized for more than a decade that there is a need for the body to 
regulate its internal mechanisms against the impact of external 
stressors. When such regulatory processes are disrupted by chronic 
stress, one possible result is a breakdown in the immune system. In 
fact, chronic stress contributes to neuroendocrine changes which can 
overcome the body's existing homeostasis. 
Each of the four psychogenic attitudes found to be significantly 
related to CD4 levels--tension, pessimism (hopelessness), despair, and 
Somatic Anxiety--may be seen as being related to the fear of death. 
There is considerable variation in the way individuals experience fear 
of death, depending on religiosity and other variables. For example, 
some individuals may fear specific physiological aspects of dying 
(pain), while others may be more existentially concerned. However, to 
the degree that their stress-related symptoms affect the immune 
function, it is important that corrective action be taken. 
PWAs are also likely to experience fear of abandonment, and this 
could contribute to the elements of stress and anxiety being measured 
in this study. Many common experiences faced by PWAs can serve to 
reinforce this fear; economic and housing discrimination and the 
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disintegration of their old social support networks are just two 
examples. Individuals may also experience anxiety and despair over the 
prospect of becoming dependent on others. 
Finally, it should also be recognized that the results should be 
interpreted with caution, given the relatively small N. Related to 
this is the limitation imposed by the dropoff in available data over 
the period of the study. Other limitations include the need to assume 
that the associations observed in the study will also exist in other 
samples of HIV seropositive subjects and that responses to the self-
report instruments utilized were valid. The use of the BDI as the 
primary instrument to measure depression may also limit the usefulness 
of the results, given the possible tendency to over-endorse somatic 
items on the scale. 
Implications for Therapy 
For the therapist working with the HIV-positive client 
demonstrating symptoms of anxiety, it is essential to develop 
strategies for reducing the client's anxiety. This may include 
teaching him to cope more effectively on a day-to-day basis, and using 
these practical "survival" skills as building blocks to reduce anxiety. 
The therapist is faced with a difficult challenge in 
implementing anxiety-reducing techniques, in that some of the anxieties 
of the HIV-positive client are, inevitably, well-founded. That is, 
there is no guarantee that the condition will not progress to AIDS, and 
there is no way to predict when that event will--or will not--occur. 
This built-in uncertainty creates tremendous pressure, and naturally 
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produces a degree of anxiety. This suggests that the therapist must 
acknowledge the reality of the client's condition, and work in a 
reality-oriented, day-to-day mode. 
Chronic stress and related psychogenic attitudes were found, in 
the current study, to be correlated wi th impaired immune syst em 
functioning. One aspect of treatment that is related to psychogenic 
attitudes is the maintenance of hope. Some researchers have reported 
on populations of HIV-positive men who have maintained high levels of 
hope and less depression. 
More generally, these findings imply that the therapist should 
give priority to controlling stress levels. One appropriate technique 
is stress management using relaxation therapy, mental imagery, and 
meditation. Stress reduction programs should incorporate an eclectic 
blend of treatment modalities . 
Clinicians must be aware of the changing psychological profile 
over the course of the disease . Individuals who are not yet 
symptomatic may be even more distressed (Chuang et al., 1989). The 
individual who is nearing death may need help in coping with the issues 
of mortality and the resolution of unfinished business (Kubler-Ross, 
1987). Yet those who are not so progressed also face major adjustment 
challenges: fears of the unknown, social isolation, and high levels of 
stress and anxiety. 
Recommendations for Future Research 
Relatively few studies have specifically linked psychosocial 
variables to both immune system markers and physical health outcome 
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(Gorman & Kertzner, 1990). There are several reasons that studies 
applying the PNI perspective to the study of AIDS have been so scarce 
(Solomon & Temoshok, 1987). It is expensive to conduct adequate 
immunological tests, and results from the longitudinal studies already 
underway are just becoming available. There is also the major 
unresolved question of identifying the lag time between psychological 
factors and immune system functioning. How long, for example, does it 
take for depression to have an effect on the immune system? And is 
that effect felt directly, or is it mediated by such variables as 
decreased compliance or participating in high-risk activities? 
While the results of the current study do not support the 
argument that depression has a direct effect on immune system 
functioning, this should be seen as inconclusive given the limits of 
the study. Further research is needed to clarify the effects of both 
depression and coping style on immune system functioning. 
Future studies should also address the need for utilizing 
relevant psychosocial measures (Temoshok, 1990). Researchers should 
utilize published measures that have demonstrated acceptable 
reliability and validity characteristics, and that have been used in 
previous immunological-oriented studies. It is essential to be 
sensitive to the unique nature of the HIV disease, and the implications 
for using certain published instruments. For example, the use of 
standard stress surveys in assessing stress in a sample of HIV-positive 
gay males who have lost numerous friends to the disease may be 
inappropriate (Temoshok, 1990). One advantage of the current study is 
that it utilizes the MBHI, which was specifica lly designed for use with 
physically ill patients and medical-behavioral decision-making issues 
in mind (Millon et al., 1982). 
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Other possible psychosocial variables that may predict immune 
system functioning need to be explored. For example, some researchers 
have suggested that there may be a "hardiness " constru ct--consisting of 
commitment, control, and challenge--that may mediate the effects on the 
immune system. This remains to be empirically evaluated, and represents 
a fruitful area for future research. Other areas in need of further 
study include (a) research on the relative effects of acute and chronic 
stress on immune system function, and (b) research on the temporal 
relationship among stres s , immune effect, and overall physical stress. 
However, the difficulties involved in conducting well-designed 
and comprehensive psychoneuroimmunologic studies are substantial. As 
Kielcolt-Glaser (1988) put it: 
... an ideal study would include multiple immunological 
samples from the same subjects over a period of several 
days ... multiple psychological measures over a two-week 
period or more ... the subjects would have a uniform physical 
activity level, and they would, of course, be remarkably 
compliant ... The most difficult subject population in this 
respect is HIV-seropositive individuals. (p. 76) 
Nevertheless, it is essential that researchers rise to the challenge 
and design innovative research studies. Such studies should be 
longitudinal in nature, following the lead of the pioneering studies 
being conducted with subjects in the San Francisco Men's Health Study 
(Burack et al., 1992). Such studies should strive to clarify the 
precise nature of the complex interaction among psychological 
variables, immune system functioning, and medical outcome. 
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RIGHTS OF HUMAN SUBJECTS IN 
MEDICAL EXPERIMENTS 
Any person who is requested to consent to participate as a subject in a research 
study involving a medical experiment or who is requested to consent on behalf of 
another has the right to: 
1. Be informed of the nature and purpose of the experiment . 
2. Be given an explanation of the procedures to be followed in the medical 
experiment, and any drug or device to be utilized. 
3. Be given a description of any anendant discomfons and risks reasonably to 
be expected from the experiment 
4. Be given an explanation of any benefits to the subject reasonably to be 
expected from the experiment, if applicable . 
5. Be given a disclosure of any appropriate alternative procedures, dru~ or 
devices that might be advantageous to the subjeet, and their relative risks and 
benefits . 
6. Be informed of the avenues of medical treatment, if any, available to the 
subject after the experiment if complications should arise. 
7. Be given an opponurtity to ask any questions concerning the experiment or 
the procedure involved. 
8. Be instructed that consent to participate in the medical experiment may be 
withdrawn at any time and the subject may discontinue participation in the 
medical experiment without prejudice. 
9. Be given a copy of any signed and dated written consent form used in 
relation to the experiment 
10. Be given an opponunity to decide to consent or not to consent to a 
medical experiment without the intervention of any element of force, fraud, 
deceit, duress, coercion, or undue influence on the subject's decision. 
"Anwrica u 1/-ThQn/cs to 011, V~rnrms•• 
v;.. ~IDI=1.L rom~ i.m LOS~. ~t:RI'H OMSI~ 
. .,;i lsture , Sawtelle Bl vds., Los Arqeles, 0. 900i3 
IIM\N snDnS C1i&R1 PCRt 
· (~en:t.rr tc W. Fon: 10-1086) 
Title c! Prct:x:cl: HIV-Related OIS Abnoraalitie• 
Re!;::cn.sible Inve!:ig!tor: Wilfred C. Van Gorp, Ph.D. 
Study t 001 Add 13 
Phone t 478-3711 
824-3174 
- .s: 
C:C-Inv-..stigat!)r(s): Calvin J. Frederlclr. 1 Pb.D. 
W.W. Tourtellotte, H.D. 1 Ph.D. 4 78-3711 
a . B~CKGkOUNU. I have been asked to participate in this study 
because I have been found to be HIV seropositive or 
setonegative (control). It is known t~t HIV and other viruses 
111.1y cause diseases of the central nervous system in soae 
patients. It is not understood how these affect the brain. why 
some patients sbow them and others do not, or bow they aiqht 
respond to various treataents. Approxi-tely lSO patients and 
~o HIV seronegative controls will be included in this study. 
b. PURPOS~: The purpose of this study is to investigate the 
occutence and manifestations of HIV related brain abnor-lities 
in various patients as they coapare with results in HIV 
seronegative control subjects. 
c. PR~UIH::S: l will be given: 
l) A neuropsycholoqic~l ~~amination Wb.ieh consists o{ an 
adult intelligence test. a test o! memory , a test of ability to 
learn and recall words or pictures, tests that will require ae to 
dta~ lines and simple figures, and a test requiring ae to rapidly 
place pegs in clot£. l will also complete brie( paper and pencil 
tests aeasurinq ay mood. This examination takes approxiutely 2 
hourc. 
2) I may be asked to have a spinal tap. This in volves 
g1v1ng blood and having a small saaplc o{ spin.l !luid ceaoved [roa 
the lower back through a thin needle. This procedure is pertoracd 
by a trained neurologist under sterile conditions. Tbe skin is 
anesthetized with a saall aaount o! local anesthetic, and tbe needlr. 
inserted into the spinal coluan aucb as the drawing of blood troa a 
vein. Approxiaately one t•blespoon o( spinal !luid will be reaovcd, 
•nd one ounce o( blood (approxiaately 2-3 teaapoon!uls) will be 
reaoved f.roa ay ara vein cvcnlpuncture). After tbe tap l will have 
to lie still for 20 ainutes on •Y side. 1 uy recuse tbe spirul tap 
but still.participate in all other coaponents o[ this study. 
-----------------
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v;.. ~DlCAL CI:)l.'TI)l ~ LOS At-Q:US, ~nsu:R!H DIVlSlCN 
· .,;ilsture, s.a-~elle Blvds., los Angeles, CA 90073 
t1.-"'H S'lU)IES CIHil!Nl' Pt:H4 
(A.±3en:3;.n t:: VA Fon: 10-1086) 
ll O 
Title of Prctxc 1 :_B:.l;..V_-_Jte_l_•_t_e_d_CNS __ Ab_o_o_raa_U_t_ie_• ______________ _ 
Re~ible Irwestig!ltcr: \lilhed C. Van Corp1 Pb.I>. 
0:-lnvutigatorl•): C.lvin J. Frederick, Pb.I>. 
W.W. Tourtelloete 1 H.D.1 Pb.I). 
Study t 001 M# 
Pbcae f 471-3711 
824-3174 
4 78-371 l 
3) A neuroloqic examin.1tion wbicb includes a liaited pbysical 
cxaa and questions. and paper and pencil tests to evaluate ay aental 
state. This examination takes approxiutely 1 bour. 
() A Positron Emission Tomography Scap (Pr:T): ln this 
procedure. a s~ll amount o! radioactive sugar (lBF-2-deoxyqlucose. 
called l'DC) will be in}ected into a vein in ay ara. Tbe aaxi•u• 
aaount o! radioactivity will be an aaount eqWll to ~best x-rays. l 
vill lie in a coa!ort.able bed while pictures are being ude oi tbe 
radioactivity in •Y brain by a special radioisotope scanner. Tbc 
entire study will take approx.iutely 2 bours. Tbe radioactivity 
vill disappear fro• •Y body rapidly. one-Ml! in lo•• tban 2 bour:. 
and all vithin 12 bours. This procedure vill be repeated every 6 
aontbs for 3 years. 
5) A Magnetic Resonance l~qfoq ~ .am.u.: This h 
porforaed with a power!ul aaqnet. Tbis tecbnlquc providos a 
detailed picture or aap of the brain. without usln9 x-r•r r•di•tion 
oc r•dio•ctive material. A specially designed coapater converts 
in!orution troa tbe iuqnetic resonance sc•n into a visible iuqe. 
No preparation is needed •nd tho scan can be pertoraed ln •bout •n 
bour. This vill be qiven to ae only once at ao•t. 
d. RlSKS AND/OR INCONVt:HlENCES: The neuropsychologic•l testinv 
will t•ke approxiaately 2 hours and ur be so~t tirin9. 
Tbe risks fro• the blood dravinq are: (l) pain troa insertion o! 
tbe needle: (2) liqbt he•dedness: (3) fainting: (4) heaatou 
(like• bruise) at the site o! needle insertion. 
Fi:Xl!f d! ki~i:tti El?!) 
.. &:it!:! l S::!1. 51=-!!!S I r ... thlll 
lt~et:1;1:e:. rf.~i!:Dt 
v;.. ~DICJ.L CE?-.":U'l --~ LOS At-Q1ES, W7.DSl'l:RI'H DIVISIOO 
~ilsh1re, Sawtelle Blvds., Los ~les, CA 90073 
11.H\N S'IU>IES ~ PCR4 
(A±lero;xr . t:: VA Fent 10-1086 l 
Title of Prct:x:cl: HIV-Related CNS Abnormalities 
Re~ible Investi~tcr: "'1lfred c. Van Co!P I Ph.D. 
O:-I,,.,...sti95~(s): Calvin J. fredertclr. 1 Ph.D. 
Y. ~- Tourtellotte, H.D. 1 Ph.D. 
Study t 001 Add.3 
Phone t 4 78-3711 
1121.-317" 
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e. BENEFITS: There m.ay be no immediate ot direct - benefit to me 
from parlicipatino in t his phase of the study. However, i! symptom:; 
suqgestinq early neurologic disorders are detected, this mioht allo~ 
!or earlier treatment. ~lso, knowledge gathered froa this study may 
help us understand more about bow and When HIV can a!(ect the 
nervous system. This may have implications for the treataent o! 
HIV-related nervous system disorders in the !iqure. Further. 1 will 
be in!oraed as to any medic~l or laboratory filldinqs that are 
iaportant to my bealtb care and my doctor will Also be notified. l 
also understand that in spite of my participation in this study, my 
condition iuy become worse. ·' 
!. ALTERNATIVES: I may decline participation in this study . 
g. Any questions I have concerning mi' participation in this study 
will be answered by: Wi!red G. Van Gorp, Ph.D .• 
Fi!le.t e Mi;C!i!!tt& fl!' .. , 
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Title cf Prctocc l : HIV-Related CNS Abno~itiu 
Re!rx:nsible J~tigstor: Wilfred C. Van Gorp, Ph.D. 
Q,-Investigatcr(s): Calvin J. Frederick, Ph.D . 
W.W. Tourtellotte, M.D. 1 Ph.D . 
Study t 001 Add 
Phone t 478-3711 
824-3174 
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h . The results of this study may be publisbed, but my name or 
identily will not be revealed. 
i. I will not be prevented from receivinq established !orms o! 
therap} ' While on this study. l! more tban trivial side eHcct:. 
directly aLtributable to the study occur, tbe study will be 
discontinued and _ routine treataent continued . 
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j. NON-VETERANS: ln the event physical injury is sustained as a 
result o! parlicipatinq in this proqram, non-veterans aay receive 
emerqency medical care and, in appropriate cases. uy be entitled to 
compensation under the provisions o! the Federal Tott Claims Act (28 
u.s.c. l346(b) , 2671 - 2680). 
k . ·w-n:RAHS: Continuiaq medical care will be provided eliqible 
veterans in the event physical injury is sustained as a result o{ 
participation in this proqcam . Aditionally. coapensation may be 
payable to eliqible veterans and 38 U.S.C. 351. or in appropriate 
cases, under the provisions o! t·ederal Tort Claiu Act (28 u . ~. c. 
1346(B), 2671 - 2680 . 
roe clarification of these laws. contact tbe VA District Counsel 
(213) 209-7379. 
l . lf 1 have complaints about the procedure or study I uy expces= 
them to Drs . Van Corp. Frederick, or Tourtellotte (investigators) or 
the co-ittee on Huaan Studies, or to tbe Associate Cllle! o! Staff 
for Research and Development. Wadsworth Division. VA Medical Centec 
West Los Anqelos. (213) (78-37 11 , extension 422(, or the Associate 
Cbie! o! Sta!(, Researcb and l>evelopment, Brentwood Division. V1\MC 
West Los lulqeles. (213) 824-3180. 
• · 1 uve received a copy or this consent for• and ay file copy ot 
tbe tbe •Rights of Huaan Subjects in Medical Experiaents.• 
--------------------------------------
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~i:sh1re, Sawtelle Blvds., Los Angeles, CJ. 90073 
IIM'N S'IU)If.S aHiENI' PtH4 
(A:!den:t.r.r t::: VA Forn . 10-1086) 
Title of Prctoc::l: HIV-Related CNS Abnonul1ties 
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Res;x:nsible lnve~ti9star: Wilfred G. Van Corp, Ph.D. 
0:-Inwstiga~r(s): C&lvin J. Frederick, Ph.D. 
W.W. Tourtellotte, M.D., Ph.D. 
Study t 001 Add I 
Ph0ne t 478-3711 
824-3174 
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The risks {rom the spinal tap are: (l) an allerqic reaction to th~ 
iodine used to cleanse the skin mani!ested by itching, a skin rash. 
or blisters: Rarely the rash or blisters uy occur throughout the 
body sur!ace; (2) an allergic reaction to tbe local anesthetic 
mani(ested by di!ficulty breathing, sweating, coldness, or light 
headedness. I! severe, the reaction can cause a drop in blood 
pressure which can very rarely .cause death: (3) Pain in the lower 
back or tingling down one leg i! the needle toucbes a nerve: (S) 
Hc4dache {or hours or days a!ter the spin.al tap. This occurs about 
10\ of the time and is rarely severe. ~roly in!ection at the 
needle site or meningitis . 
H l am given .i Pt:'l· scan. FOG is not metabolized norully by the 
body, but in this study only minute doses will be adaini~tnred, less 
than one-ten-thousandth o! the amount roquired to sbow pharucoloqic 
or behavioral ettect. lt will be excreted in •Y urine a!ter 
administration within 12 hours. The whole body radiation dose !or 
each study is less than 1/lS o! the ~nnual peraitted dose to 
radiation workers, and is less than that received should 1 have an 
x-ray examination of my spine or qastro-intestinAl tract. The 
amount 1 will receive is well within those liaits that have been 
accepted by the Nuclear Requlatory Comaission tor radiation 
workers. Tbese are liaits which have been developed and care!ully 
reviewed by natio~lly and internationally recoqnized qcoups o! 
scientists. 
There are no known risks associated with tbe MRI scan, except 
possibly !oc fatlque oc boredom. 
--------------------------------------------
F2;11tt Cf R!i;:tni!Eli Fi?tS 
lh,'!!:I;!'!tt . r:':!.'t!eli~ 
114 
L::111' -.! SK 
1 Hcu;IJ!" ro HIG~ RISK ST UOY No . 000 1 Add ,J 
r ,1.n l•4QU11fln' TO ,,_.TIC:J,-4T! IN l!SEA•~ 
IY 011 u,,11u TH! DttttC11C>C o, lltf •!TO.ulS I.D<IIIIIHU T10N 
I .... 
I I. _...._..,...._,_,...........,._ .. . ,, 
n,- • _,,_, ~.,.. _.. 
.............. ._, _,.....,. HIV Related OIS Abno 1'9111 ti es 
,,,.,. .... , 
I "-"'" ac--1 - •....., .. ..,._. .. -....U .... ttii. WW .. - aft 1-.W ..... t .... ~ ...... "'IC Ulla,.,.,._. .. aa4.-..i lJW 
... ,.- . (.- , - • . ' "" ,...,,.~- i. - ...... uw .......... .,...L _,,,.'""""" __. ..,_._, le•"~ -•..,. M • ..,. """""- e4 aw.....,...•• .. 
~ _.., n.;-<'11 LO••,_.~,. "-- IIW ------ && MT - - LM'tl •f Ull'W .,_. - ..... ~ le - .,. UW ~ • i.-.,.,...... e4 I 1"-.. 
n.,.....,,n-C>toitll.ua.W"'1ay .... -,,........_.,._..,._....,_ .... 1 ....... 1 .......... .._ • ......_ 
l , ........ YftdtJUl .. ,.........,... ................. "'""' .................... ,.~------.n-.... .  __. . 
IUI• "'"'"'"" , ..,111 I~ I .... ~ W .... ,_..,.., ...... - IN ... - ............ .,, -.W __ .... ,.... , _. UWI......, .......... 
,_..__ .......... - ~· - · I.a ...... , . ,...«1 .,. .......... 
I. '" ,..., ......,_ I ._. ... ~ .,_... • a __. ., ,..,.,.... ... • ._ 
ltl ____________ .. _,._ 
......... ,..... ,_., _,. m ,...,..._ tf 1- - IIIIP96t ._ .......... • • ......._ t """......., .................. ~ 
l 
, _  , _ _ ,, ...... ,, 
.., ... ~--..,...., ........ .,. . .,,......,. 
........ ,...----~..-c ............... ~ 
• 1 ........... , ............ _ ................. __ .,_..., .. _ .... .......,_,., ........................ 
~='=-=:.7.::.., ~ -==.;-:-.::; .-:-.:.: ..=-...:. '::'tt..:.. ... ~:n-, · ·" ....... _,. * ..... 
~ .. =~~~c:::::~, = ~=·~ ~ ~-.:::.~.: = ~-:-::'~:. ~~= 
"'-l .. :ftWllf'M ......... ....,. ... 1'lw,........., 1M """-7 M'\....,  "' ........ 
ll t111tw_....t, ... ,_,_... ...... ,,..,..... ....... ~ ............. ~.., ....... - ....... , ............... 1.a 
~~ ,_.__....ca,t ~., ._... ... -.-...u, ....... . n. _,__._ .......... IA...,_ .... I • ., I.Ml ICM.t1191 IN --.14.._ 
I 
".um M YO&.Uto-nzll 
~~~i~~--~?L!14~~ r'.:'~"#t_~ ~~~IU~:~ :-~Uf,'tl"-~1~,2,,E1:;;L_~ 
"·""T ..1L,u. I •r.au TO P..1anc..4n; .4a A YOUJ:\-nD L"I' nu, noc.LUC . 
' 
'-"'"J'WW'ol.i. I....,_"" .................... la.,...._.. ....... : 
PLLAst SU ATTAOIED A.0CID(DA TO ffIJ ~ real 10-lOM 
5 (No. of addend.- attac:be41 
... ••CM., • .,. ....,.c-r,...,..,,..c 
691 VA14C. West LOS Anoeles lllds .a l"ttl Oh . 
.. , ...... , __ ............ ,._ _, _........., .. , ... 
_..,., . ,~ ..... ._ .. _, _.. ... , .... 'f_ 
o"'--......... _ ......, o~=-:. : 
-~l""'leca•-CA,._C.A_•.,.__ . ._. .... ....,, _..,.....,_ 1-
AGIIUJIINT TO ,.,..11al'A Tl • 
llfSIAac>c IT OIi """'' 1'4! DIMCTIOII 
0, TIit YfT!IMIS ADa•OI TU TDf 
:::=~-
._...._ec, .. ,_ ...... 
............. .__... .,.
---
, •• r II • •c.a!!dNT IT SUIJfCT"S ltPltfif"-UTIYf TO AU.OW SiJIJfCT TO ,ur,ol'AT! 1 •• • • 
IM ltflf .. 04 8T 011 UNOU TH! Dl•ECTION o, 'l'!T!UJCS 40MtMISTh TION 
, _ L _ _....... . " .. ~- , 
,,,.,,. -__, - -' ...... ,.  , .....,..., 
, .. 
-.--,1,.,. . .... ...,..,...., , ........... --' ...... --"'... , 
I ...... i."IY ___, ...... JIii-- -~- .. e ...,_. • ............ _,&NIii 
rr .. •-' ..,., 
1 I Mft ...,....s _.. • .... witona.Maa ....,, w1Ctl .,_ "'- • ..,. -.& I -..., ................. 91r 11,a -. IN~ aM a,w,. et urt-
O'l"11"100" . UM ..,.....VN'I liO • .... . .. Ill&&. we saw-. _.. tfSft1&. 111111111 --Au••~ -• ..U • ectwt ~el.,..,.,.,,.....,,.,""' 
Jl'\d ,_., nfft l t,,o .-n:Wftw ttw --..Cl fNa Ull,t _._"Pl*' U M"f .... . l.iiim et .... IU"IIII ............... IO .. t'Y IN~• la.~ 
oC • ...... . 1'N .....upwMI ...... ay ................. __,,.,_ ... I_..... all 1 ......... wM& • ........ . l , ____ .. ________ .. ____ ,_ 
xcsw .. w~~-......,_. ., .... -...... ______ .. ,. ___  ..... ____ .., -
...... .... IM&...,,. .. ..... 
Pf'KallUN•161• ...... ....., ............ , .. ......,_ 
~ 1ft UM ~ t dW .. __, _..,.. ,..,..... W\l¥fY MI fWlltt sf~ a 111111' r-et•tte . If'*- -,..n ......... tN ~ ._,. • t WWf'llf'I . Il l 
IWC'N,Mf)' 1-· .. ,~._..,u .. ,......._u .. ..._...w,........_...._.c-. •• ........_b c::rtt....,._,,.._..~ .. 
PN• ..... . 
! I ,..,1,. I ~ .. , ........ d\a ....ibrl*'I tr'llla ~le, ......... . c-, 
...,, •."" ,,.,. ... ,. .....ca.-., ......... ....,.,,...,_ • - ~ • ..,. w at ,a7'111Nt. • .., ""' sf "'JVC"l,I 111,wy 
' I -"WW, WI Ill ml- - - llw .............. -- - el - ....,, will IN - - _to.__...,. .. l"'C ~ 
ot tM ... e,,uU\.d&e~~lflalalV.....,..,......,.._ ... Y ... ~aena..........,.,..~ . nw,,-,,JN...,.NI.,. 
CM..,.. """'".,.,-a\"•---"., we,en ·, ,,.._, _. ....,...cy • """1, 1e au ..-a.i,..,..... 1NMI ... , . ...,... Ma.•&n.Delt . 1. ,,..,,_.,.. ___ :i-=.., ...... _ __. ___ ril _____ , __ .,_ .. ..., 
t~ .::..~ ~~+.,"*~ ":"" .. -;::.,·.-·=-~=----- - - - ... ,-117 -
· - lnt1w_ , __ ., ___ -...i ___________ .... _,..,,_ ..... _.,_ 
.. ' "PP4...S to I IW ......,.. ~ ................ ..._.,~ . TM.,.......,. 91M ........ IO..,.,,.. .......... , 1W 
Wb1'""\ C"W\f'IOC - ... u.!Ne . . 
I 
;>j,Uj t or SL"IIECT"I I.Uu:sLYr A T?Vt 
HAvt UAD TlllS C:ONIZ:ff rob . AU WT Ql'UT10't'S NAvt IEnl .. ~all) . A.'ttl I nUtLT A~'t) 
VOl. l.~"TARILY CM00u. THAT THt 11.~C'T PAllTlCTPATt . I t: :-tOtllS'TA)IO THAT Tiff: R....,EC:-:-"'S ll lCHTS 
.. ~ Plll'IIACY Wll.1. ")&ALVTAr.'fU> . I A.CllU T0 Tia It.~ PAllTlCTPAT!Ni 4S .. vou;:-.-ri:r.a Di 
TH IS PROCLUI . 
I . :-. ........... . .. - ..... ~ ---- .... _..,._. __ !Gllewo : 
• co•c.u.,. --.i&cT-. ..,.._N••.a•..a - • .... . ...., ........ ____ --___ .,. ··--
_, .. ,.. , ..... ·-...... ,_ .. ...., 
-
-- -- -
\..a,ICT "I -- ~ - --., We.ACT• - & -"911T .6 --. ..... __ , 
..... ,.... , ... , -~c,i-,.-..., 
-· - - --
D ~.::::::- o:=::=-...-:.: 
1-.e,ccr, ,ec.• 1, .:..a, ... ~., ... _.._ • ...., .__,__.. , 
......... c ........... . 1- , .... 
.lCIIIMIIIT IT 11/IUICT'I 
llf'IUINUTIWI TO 'HTICIPATI 
* lllf•ICII IT 01 IIIIOII 
TIii IIIICTIOtl o, nu 
w•T•a£MI .aow1wnT•••""-
116 
Appendix B 
Millon Behavioral Health Inventory 
Name: ____________ _ 
Date: ____________ _ 
KILIAN BEHAVIORAL HEALTH INVUITOR'i 
INSTRUCTIONS: Th• tollo\ling are state.111ents that people us• to describe 
themselves, their heling• and attitude• about health. Try to be as 
honest as you can in marking the atate..ments. A tew ot the statements may 
seem unusual to you, but do not be concerned; they are included to 
describe a vid• range ot people vith many type• ot problems. W'hen you 
agree or aostly agree vith a atatement or decide that it describes you, 
circle In,le. It you dlaa~ with a statement or decide that it does not 
describe you, circle lalae. Try to mark every statament even it you are 
not sure ot your choice. It you have tried your beat and still cannot 
decide, mark Fal••· 
T F 
T F 
T r 
T F 
T F 
T F 
T F 
T F 
T F 
T 't 
T F 
T F 
T F 
T F 
T F 
T F 
1. I have alway• been able to overcoir.e the probleu I've had. 
2. Lately, lit• haa been going along aa usual, vith no apecial 
thing• happening. 
J. When I waa a young child, •Y parent. telt very proud ot me. 
,. I have almoat never been sick. 
5. I have friend• vho vill listen to any probl ... I have. 
6. I like to be the on• in authority to ta.It• charge ot things. 
7. It I v•r• very aick, I'• •ur• that everything vould vork out 
vell. 
a. I alway• take the medicine a doctor tell• .. to even it I don't 
think it ia working. 
9. I a.a very pleaaed vith all th• thing• I have don• up to nov. 
10. I alaoat never !eel pressure in the vork I do. 
11. I get very frightened Yhen I thinlt of being all alone in the 
world. 
12. I u ready to attack anyone Yho triea to say ter-rible things 
about ... 
13. I have a feeling that thing• in rJ lite juat go from bad to 
vor ... 
u': .Ul ay. lit• I have had to ·blov up• every nov and then. 
15. Thia year I vaa auccesatul at something that vaa very important 
to ... 
16. I aa 1n better h .. lth th4n 110.t ot rt friend.a. 
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T f 17. A quiet hobby 1• more tun tor m• than a party. 
T F 18. Host people wouldn't car• auch it I were very sick. 
T F 19. I often say things that I regret having said. 
T f 20. I have lots ot plan• ot what I'd like to b• doing ten 
years trom nov. 
T r 21. I have a lot ot taith that doctor• can cur• any sickness. 
T r 22. People can intluenc• •• quit• easily. 
T f 23. I often !ind time to take it easy and do nothing. 
T f 24. Even in ditticult times, I alvays try to~ cheertul. 
T r 25, I don't mind that other paopl• are not int.rested in my 
friendship. 
-
T r 26. I've had aerioWI money probllllU this year. 
T r 27 . I almost always have aedical problui.a, 
T r 28 . I otten teel that others do not vant to~ triendly to••· 
T r 29. It I bec&llle 111, I wouldn't have auch help !roa ay !amily. 
T r 30. In llAny vaya I teel very au~rior to aoat paople. 
T F 31. It I ever got a aerioua illness, I think it vould be the 
end ot ae. 
T r 32. No matter vhat, seeing a doctor can aak• .. t••l better. 
T F 33. So little ot vbat I have done has been appreciated by others. 
T r 34. ~••ping to a ti•• sch~• i• not i.Aport.ant to••· 
T F 35. I've done aoat thing• in ay lite very vell. 
T r 36. When I thinlt about the paat, I r-eaber aoatly the good things. 
T r 37. I.. a.alt• naaty reaarka to people if they d ... rv• it. 
T P JI. I have had aore than ay share of troublu 1n th• paat. 
T P J'i". It 1a -4ood to have a regular vay of doinc, thing• to avoid 
aista.Jt.ea. 
T P 40. Many people have !Men apying into ay private life tor years. 
T r 41. I alao.-t never vorry about ay 11••1 th. 
T r 42. It I thought I had a serious sicl<.ness, I would quickly tan. 
it over with my tamily. 
T r 4J, There are alvays a number ot reasons why most problems can't 
be solved. 
T F 44. I look tor-.ard to the tuture Yith lots ot hope. 
T r 45, I do my best to get along with other• by being pleasant and 
agreeable. 
T r 46, All doctor• care about i a ay 110ney. 
T r 47. I get upset vhen things I don't expect happen to me. 
T r 48. I otten get angry with ~ople who do things slowly. 
T r 49, I don't depend much on other people tor triAndship. 
T r 50. I te!l pretty upset about moat thing• in •Y lite. 
T r 51. It ia very ditticult tor .. to atop teelinq• troa coaing out. 
T r 52. My family has had really bad proble&.a in th• past year. 
T r 5J . I can stand a lot ot ~in. 
T r 54 . I like to tlirt a lot. 
T r 55. In time ot trou.ble, there are several trienda that I can 
depend on. 
T P 56 . Most people can be tnated to be kind and thoughttul . 
T F · 57, Even it I were vary sick, I'd keep tigbting and never give up 
T F 58. I sometimes t••l I &JI in thia world all alone. 
T r 59. I t••l that the doctor-a I have Men are not interested 
in •Y probl .... 
T r 60. I &JI a dra..atic and ahc,yy sort of person. 
T r 61. I- can't aund people vbo are late for •ppointaenta. 
T r 62. I do •Y beat to atop anyone froa tryinq to boH ••. 
T r 63'": I otten thi.n>c about unhAppy - thinga thAt have happened to ••· 
T r 64. I otten do thinqa for no r...on other than it aight be fun. 
T r 65. During the paat year, soaeone _ close to ae baa been very ill. 
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T F 66. I guess I'm a complainer who expects the worst to happen. 
T r 67. It i• not W'\uaual to !eel lonely and unwanted. 
T r 68. I worry a lot about •Y health. 
T r 69 . Lots o~ people would care about me it I became very aick. 
T F 70. I would much rather tollov aomeon• than be the leader. 
T r 7l. It I had a very aerioua aickn•••, I thinlt I vould tall apart 
mentally. 
T r 72. To get ahead in thia world I'• willing to puah people who get 
in •Y vay. 
T r 73. Doctor• have alway• been helpful to••· 
T r 74. I find it hard to !eel aorry tor people who are alway• 
worried about thing•. 
T ? 75. I ••ea to tit in right away with any groupa ot people I meet. 
T P 76. I like being in a crovd juat to be vith lota ot people. 
T r 77. Moat ot •Y probleJU juat go on and on. 
T r 78. I gue•• I de~nd too ll\lch on other• to be helpful to me. 
T r 79 . I moved during the pa1t year. 
T r 80. I have alway• telt eoae kind of problea ~t~••n me and the 
oppoait• sex . 
T 1 8l. I get frightened when I thinlt I have a ••dical problea. 
T 1 82 . Punishment never atopped .. fro• doing vhatever I wanted. 
T 1 83. I would have lota of viaitora it I were in the hospital. 
T 1 84, AAonq th• moat important thinq• a peraon can have are a 
atronq will &nd the drive to get ahead. 
T 1 a,. I would never let a Hriou8 aic>cnea8 _atop .. troa working 
tovard the tuture. 
T P 86. I often feel 80 anqry that I vant to throv &nd brea.Jc thinga. 
T , 87. I diai.l.Jte going to docton; and do 80 only atter trying 
everything ayaelt. 
T P 88. I really hate to have rt work pile up. 
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T f 89. I !ind it hard to take my mind o!f my work even when I '111 
supposed to be relaxing. 
T F 90, I have not seen a car in the last ten years. 
T F 91. I very often think I am not wanted by other• in a group . 
T F 92 , Even when things seem to be going well, I expect that 
they'll 100n get vor••· 
T F 93. I vould rather be direct with people than avoid telling 
th•• 1omething they don't like. 
T r 94 . Many important thing• have happened in ay lit• this past year . 
T r 95 . What this country really needs are aore serious and devoted 
citizens. 
T r 96. At no ti.a• in my lite have I had any hair on my head or my 
body. 
T F 97 . TV progra.9 a.bout illness make•• very upaet. 
T F 98 , Ever sine• I vaa a child I have been loainq touch with 
th• real vorld . 
T F 99 . I ~Mot depend on my ta.aily .,..hen I ne~ th••· 
T F 100. I like to tell other• about th• thing• I have done well . 
T F 101 . I'd rather be dead than have a very ••riou. aickness . 
T F 102. I u.ually let other people have their ovn vay. 
T F 103. I usually von't take any aedicin••, even it a doctor 
tell• 1H to. 
T F 104. I vish th• people around•• vould aov• taater and get more 
things done. 
T F 105. I often tael that there 1• nothing I can do to aaxa •Y lit• 
eaaiar. 
T F 106. I have very tav clo•• ~raonal ti•• vith othen . 
T F 107. Thia part year haa been one ot the 110at difficult ones 
in sy lite. 
T F 101': It I thouqbt I var• getting . aiclt, I would quickly 
call a · doc:to r . 
T F 109. I have a strong desire to vin any g ... I play vith others. 
T r 110. Nobody really caru about ay •tate ot health. 
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T f 111, I have taith that human nature ia good. 
T f 112, I haven't thought auch about what I'll be doing a year 
troa nov. 
T r 113, All ray lite I have had th• teelinq that I have don• 
something terribly vronq or evil. 
T r 114. When 1omeone hurta ••, I try to torget it. 
T r 115. Hospital• are trightening and lonely places to be in. 
T F 116, My vork makea me tens• almost all the time. 
T F 117, I have flown acroaa the Atlantic JO time• laat year . 
T r 111. In thia vorld you either push or get shoved. 
T r 119. It Iver• young again, I would do thing• very ditterently. 
T F 120. It i• very important that children learn to obey 
their eldera. 
T F 121, I've had a lot ot ehock.a and diaappoinUent• thia paat year. 
T F 122. Rather than dea.and thing•, people can get vbat they vant by 
being gentle And thoughttul . 
T F 123, I get v.ry upaet vhen I teel pain in any part ot •Y body. 
T r 124, I can aN aore aidu ot a probl- better than other• can. 
T F 125. It Iver• getting aiclt, II vouldn't vaat• ray time telling 
anyone in ay taiaily. 
T r 126 . I .. 110re vorried about tiniahing thing• that I atart than 
aoat people, 
T r 127. For .. , the future locka like it vill be tull ot trouble 
and probl_.. 
T r 121. I do rt but not to hurt people'• t .. linga. 
T r 129. I have never telt 11Uch lite in ••· 
T r 130. I vow.d rather be in ~in than taJce any aedicinea. 
T F 131. I otten doubt whether people are really intereated 
in vbat I u aayi.ng to th ... 
T P 132, It 1a very euy tor H to relax and elov dovn. 
T P 133. I don't knov vbat I vant out ot lite. 
122 
T r 134. Lite ha• never gone well tor me. 
T r 135. I've been touchy or teartul about everything most ot my li!e . 
T F 136. I u very uneasy when I have to tell people what to do. 
T r 137. I am too rushed and buay to take the vacations I should. 
T r 1)8. There has recently been an important change in my job. 
T r 139. I like to tollov inatructiona and do vhat others expect o! me. 
T r 140. I otten thinlt that I have a serioua illness. 
T r 141. I am a quiet and cooperative person. 
T r 142. I'd be a pretty lonely peraon it I ever vere hospitalized. 
T F 143 . I become very excited or upaet once a veek or more. 
T F 144. I alvaya try to do vhat i• proper. 
T F 145. I don't thinlt I would vant to go on living it my body vaa 
marked up a lot in a ••riou. operation. 
T F 146. I get •o touchy t.hat I ~·t talk about certain thinga, 
T F 147. From thing• I hear about t.h••, I don't trust the people who 
work in hospital•. 
T F 148. I have a atrong need to teel like an important person. 
T r 149. My day is tilled vith preaaur•• a.nd responsibilitie•. 
T F 150. I like to arrange thing• dovn tot.he last detail. 
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Appendix C 
Beck Depression Inventory 
\lame: 
~te: 
l'-STRUCT!GNS: On tnu que,tionnaire ut 9r0\..0, of ,tHe11ents. Pltue r!!'!.:i ~acr, 
qrOVP of ,tatements carefully . Then pick OIJt the one ,tate,,,~t in eac.., ;.:-:1....:l 
tl"lat tie,t de,cr1tie, the wey you have tleen feellnq the PAST w(EK, l\Cl. '..0!'.: -:oAY. 
Circl e the null'()er beude the statement you p1c\ced. If ,everal ,tatt'"'e'"lt: ~:- the 
grO<..(J ,eem to apply equally well, circle eacn 0('19. Se ,ure to re.id a~ :-e 
stateme nt, in eac'"I qrot..0 tlefore -n.1<1nq your cl'lo1ce. 
1 • ( 0 I do "O t feel sad. 
1 I feel sad. 
2 l am sad all the time and I can't sn.io 01.1t of it. 
J I am so sad or unh.icoy t/'\at l can't stand it. 
2. ( 0 l am Mt partiC1.Jlarly discounqttd abO<Jt t/'\e future. 
1 l feel discour-aqed about the future. 
2 I feel I have nothing to look for--1rd to. 
J l feel t/'\at the future 1s hopeless and tnat ttiinq~ cannot il!'Ore•e. 
). ( 0 I do t"IOt feel like a failure. 
1 l feel I have faded more than the averaqe person. 
2 A1 I look back on rrry life, all I can aee i1 1 lot of failures. 
J l feel I a11 a COl!'l'lete failur1 u a person. 
4. ( 0 I qet as 111.Jch satisfaction 01.1t of things u used to. 
1 I don't ef'ljoy things the way I used to . 
2 l don't qet real satisfaction out: or anything any1110re. 
J I am dissttisfie-d or bored with everything. 
~- t · ) 0 don't reel partic:vlarly guilty. 
1 feel guilty a good part or the time. 
Z reel qulie guilty most of the time . 
J feel guilty all the time. 
6 . ( 0 don't feel [ u being punished. 
1 reel I may be punished. 
2 exceet to be punished. 
J feel I a111 being punished. 
7. ( O don't feel disaopointed in 111yse1'. 
1 am disappointed i.n ~self. 
2 ill disgusted with lll'yHH', 
J h.at:e lllyHH', 
8. ( 0 I don't: fNl I u any worn U-.n anybody elu. 
1 I aa critical or ayself for 11y wukl'IHIH or llistaku. 
2 I bla.- ayHlf all the t:ime for ., f~lts. 
J I blaae .,,.lf for everything bed thlt ~per,1 . 
9. ( O I don't heve any thouqhts or kilHnq ll'fHlf • 
... 1 I !'\ave thought's or killing myself, but: I would not: carry t:near ou:. 
2 I would like t:a kill cnyself. · 
3 I would kill myself if I had the ehlnc:e. 
10. ( 0 I don't: cry any 1110r1 t:hln usual. 
1 I cry aore then I used t:o. 
2 I cry all the t:iJM now. 
J I used to be able t:o cry, but: now I can't: ever, though I want~~. 
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11. 0 .m no "'ore I rri tate-c new than [ ever .m. 
1 grt anr,oyed or irritated more eas lly t l",.n [ " sed to. 
2 feel 1rr 1t1tt<l ill t he time no-,,, 
) dOt'I' t get irr.tHtd it all by the t Mi.nq, t r.at us~ to ir::--: t . : ! -ie . 
12. ( 0 heve not lost interest in other people. 
13. ( 
14. ( 
15. ( 
1 111 less in•ereste<i in other peoele t~n l used to be. 
2 ~ ve lost most of ,,iy i nterest in ot Mer oeocle. 
) l'\ave lo st all or "'Y interest in other peocle . 
0 1113ke dec 1s1ons a00<.1t as well as le ver c0<.1ld. 
1 put err ~k i.ng dec i.uet'I more t han l used to. 
2 have greater difficulty in 11111<1nq decu 10f\s ti"lan be for~ . 
J can't ~ke d1tei11on1 1t 111 anymore. · 
0 don ' t feel I look any worse than I used t o. 
1 a~ worried that I•• lookir,q old or ur.at t ractive. 
2 feel that tMere are permaMnt ct-.nqes 1n lff'f ~purtl"\Ce tr.at .ks 
~e look ur.attr,ctive. 
3 I believe that I loolc ugly, 
0 I can work about 11 well 11 before. 
1 It takes an extra effort to 9et 1tuted at doing ,~thing. 
2 ! Meve to pu1M myself very herd to do anythinq. 
3 I can't do any woric at all. 
0 I can sleep 11 well 11 uaial. 
1 I don ' t sleeo as ~ell•• I used to. 
Z r ,..ke IJQ 1-2 !-.ours earlier than usual and find it '"-rd to get 
O1c1< to slee::, . 
3 I .. 'lke ~ several hol.in urlier than us~ to and cannot get 
back to sleep. 
17 . ( 0 '1un' t get more tired than usual. 
1 get tired mort easily tl\an I used to. 
2 get tired fr0111 doinq 1l1110st anything. 
3 1111 too tired to do anyth.ing. 
18. ( 0 My aooetlte is no worse tl\an uau.l. 
19 . ( 
20. 
21. ( 
My aooet1 t1 i 1 net as good 11 it used to be . 
2 My aooeti t • i.s a.ich lfOrae now. 
3 l\ave no appetite at all 1ny110u. 
0 I l\aven't lost 111..Ch weight, 1' any, la t el :, . 
1 I have lost 110u tl'lan 5 pouncn. 
2 I ,..ve loat aon thaft 10 pounda. 
:, I l'lav! lost 110n than 15 pounds. 
I aa pur-poHly trying to loH weight b~ eating lus: YE= 
0 u no 1110n worried about .., health than usual . 
I aa worried at:out ., physical procl ... such 11 1cl'IH arc pa..i~: 
or I.C)Ht atomacn: or con1tip1tlon. 
·z I a,. very worried about., phyaicll probl11111 and 1t'1 ha~ ~ 
think or 11UCh el11. 
) I u so worried about ., physical probl"'9, thet I carroot tr..in1,; 
about anything else. 
0 I have not notic.cl any recant char,qe in ""f int1r11t in sn. 
1 I u 1111 int1r1st.cl in sex then I used to be. 
Z I a,. muc:h le11 int1ruttd in sex no-,. 
) I have lost int1re1t in 11x C0ffll)l1t1ly, 
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